NZ712773B2 - Process and system for preparing dry milk formulae - Google Patents
Process and system for preparing dry milk formulae Download PDFInfo
- Publication number
- NZ712773B2 NZ712773B2 NZ712773A NZ71277314A NZ712773B2 NZ 712773 B2 NZ712773 B2 NZ 712773B2 NZ 712773 A NZ712773 A NZ 712773A NZ 71277314 A NZ71277314 A NZ 71277314A NZ 712773 B2 NZ712773 B2 NZ 712773B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- originating
- permeate
- whey
- drying
- softened
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 112
- 230000008569 process Effects 0.000 title claims abstract description 88
- 235000013336 milk Nutrition 0.000 title description 26
- 239000008267 milk Substances 0.000 title description 26
- 210000004080 milk Anatomy 0.000 title description 26
- 239000000203 mixture Substances 0.000 claims abstract description 285
- 150000002500 ions Chemical class 0.000 claims abstract description 226
- 239000012466 permeate Substances 0.000 claims abstract description 194
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 190
- 241001465754 Metazoa Species 0.000 claims abstract description 149
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 147
- 239000012465 retentate Substances 0.000 claims abstract description 131
- 239000005862 Whey Substances 0.000 claims abstract description 125
- 238000001035 drying Methods 0.000 claims abstract description 113
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 101
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 95
- 239000000047 product Substances 0.000 claims abstract description 93
- 235000018102 proteins Nutrition 0.000 claims abstract description 75
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 75
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 75
- 235000013350 formula milk Nutrition 0.000 claims abstract description 73
- 239000005018 casein Substances 0.000 claims abstract description 71
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 71
- 235000021240 caseins Nutrition 0.000 claims abstract description 71
- 235000021119 whey protein Nutrition 0.000 claims abstract description 65
- 239000007788 liquid Substances 0.000 claims description 180
- 238000002156 mixing Methods 0.000 claims description 86
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 70
- 239000012528 membrane Substances 0.000 claims description 70
- 239000008101 lactose Substances 0.000 claims description 69
- 238000001728 nano-filtration Methods 0.000 claims description 54
- 238000012545 processing Methods 0.000 claims description 28
- 238000007599 discharging Methods 0.000 claims description 24
- 238000001223 reverse osmosis Methods 0.000 claims description 21
- 238000005342 ion exchange Methods 0.000 claims description 19
- 238000000909 electrodialysis Methods 0.000 claims description 18
- 238000001556 precipitation Methods 0.000 claims description 18
- 235000016709 nutrition Nutrition 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 16
- 238000002425 crystallisation Methods 0.000 claims description 7
- 230000008025 crystallization Effects 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 230000035764 nutrition Effects 0.000 claims description 4
- 238000010793 Steam injection (oil industry) Methods 0.000 claims description 2
- 239000007787 solid Substances 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 229910052500 inorganic mineral Inorganic materials 0.000 description 30
- 239000011707 mineral Substances 0.000 description 30
- 235000010755 mineral Nutrition 0.000 description 30
- 239000000843 powder Substances 0.000 description 30
- 235000008504 concentrate Nutrition 0.000 description 25
- 239000012141 concentrate Substances 0.000 description 25
- 239000011575 calcium Substances 0.000 description 18
- 239000011777 magnesium Substances 0.000 description 18
- 239000011734 sodium Substances 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 17
- 239000012530 fluid Substances 0.000 description 17
- 238000010438 heat treatment Methods 0.000 description 16
- 238000001914 filtration Methods 0.000 description 13
- 101100079886 Lactobacillus johnsonii (strain CNCM I-12250 / La1 / NCC 533) nfr2 gene Proteins 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 241000283690 Bos taurus Species 0.000 description 10
- 102000014171 Milk Proteins Human genes 0.000 description 10
- 108010011756 Milk Proteins Proteins 0.000 description 10
- 238000005115 demineralization Methods 0.000 description 10
- 235000021125 infant nutrition Nutrition 0.000 description 10
- 235000021239 milk protein Nutrition 0.000 description 10
- 239000008247 solid mixture Substances 0.000 description 10
- 239000007858 starting material Substances 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 235000013365 dairy product Nutrition 0.000 description 8
- 239000003925 fat Substances 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000009928 pasteurization Methods 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 235000020244 animal milk Nutrition 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000013351 cheese Nutrition 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 235000020256 human milk Nutrition 0.000 description 5
- 210000004251 human milk Anatomy 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 230000009469 supplementation Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 238000011026 diafiltration Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- 102000004407 Lactalbumin Human genes 0.000 description 3
- 108090000942 Lactalbumin Proteins 0.000 description 3
- 108010063045 Lactoferrin Proteins 0.000 description 3
- 102000010445 Lactoferrin Human genes 0.000 description 3
- 108010023244 Lactoperoxidase Proteins 0.000 description 3
- 102000045576 Lactoperoxidases Human genes 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- -1 citric acid) Chemical class 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000002328 demineralizing effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 3
- 235000021242 lactoferrin Nutrition 0.000 description 3
- 229940078795 lactoferrin Drugs 0.000 description 3
- 229940057428 lactoperoxidase Drugs 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 235000021241 α-lactalbumin Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229940071162 caseinate Drugs 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 235000014666 liquid concentrate Nutrition 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 101100070542 Podospora anserina het-s gene Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229940023913 cation exchange resins Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000011552 falling film Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000013529 heat transfer fluid Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 150000002597 lactoses Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 238000000247 postprecipitation Methods 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940108461 rennet Drugs 0.000 description 1
- 108010058314 rennet Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000020209 toddler milk formula Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000010977 unit operation Methods 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C1/00—Concentration, evaporation or drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C1/00—Concentration, evaporation or drying
- A23C1/12—Concentration by evaporation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1425—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of whey, e.g. treatment of the UF permeate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/144—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by electrical means, e.g. electrodialysis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
- A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to a process and system for obtaining a dry milk formula, comprising the steps of (a-i) ultrafiltration of an animal skim milk composition comprising 70 - 90 wt% casein and 10 - 30 wt% whey proteins, based on total protein, and (a-ii) ultrafiltration of an animal whey composition comprising 0 - 25 wt% casein and 75 - 100 wt% whey proteins, based on total protein; or (a-iii) ultrafiltration of a mixture of the compositions of (a-i) and (a-ii), (b) preferably combining of the UF retentate originating from step (a-i) with the UF retentate originating from step (a-ii); (c) removing polyvalent ions from the UF permeate originating from step (a-i) and/or (a-ii) or (a-iii) to obtain at least one softened UF permeate; (d) combining the at least one softened UF permeate originating from step (c) with a UF retentate originating from step (a-i) and/or (a-ii), or (a-iii) or (b) to obtain a combined product; and (e-i) drying the combined product originating from step (d) to obtain a dry milk formula, and/or (e-ii) drying any UF retentate originating from step (a-i) and/or (a-ii) or (a-iii) or (b) which is not combined in step (d), and drying any of the softened UF permeates originating from step (c) which is not combined in step (d), followed by combining the dried UF retentate with the dried softened UF permeate to obtain a dry milk formula. omposition comprising 0 - 25 wt% casein and 75 - 100 wt% whey proteins, based on total protein; or (a-iii) ultrafiltration of a mixture of the compositions of (a-i) and (a-ii), (b) preferably combining of the UF retentate originating from step (a-i) with the UF retentate originating from step (a-ii); (c) removing polyvalent ions from the UF permeate originating from step (a-i) and/or (a-ii) or (a-iii) to obtain at least one softened UF permeate; (d) combining the at least one softened UF permeate originating from step (c) with a UF retentate originating from step (a-i) and/or (a-ii), or (a-iii) or (b) to obtain a combined product; and (e-i) drying the combined product originating from step (d) to obtain a dry milk formula, and/or (e-ii) drying any UF retentate originating from step (a-i) and/or (a-ii) or (a-iii) or (b) which is not combined in step (d), and drying any of the softened UF permeates originating from step (c) which is not combined in step (d), followed by combining the dried UF retentate with the dried softened UF permeate to obtain a dry milk formula.
Description
/050202
Process and system for preparing dry milk formulae
The present invention relates to an advanced process for treating animal skim milk and
animal whey, preferably for the manufacture of dry milk formulae such as infant milk
formulae and other nutritional products for infants, as well as a system designed to
implement the process according to the invention.
Background of the invention
Human milk is considered the ‘golden standard’ for infant ion. Processing animal milk,
for example cow’s milk, to more resemble the composition of human milk is known in the
art. Such processing is known in the art as ‘humanizing’ animal milk. The process of
humanizing animal milk es changing the ratio of casein:whey proteins as found in
animal milk (e.g. approximately 80:20 for cows’ milk) to the desired ratio for infant
nutrition as found in human milk (preferably between 75:25 and 30:70). In on, the
mineral content of animal milk is typically higher that the content found in human milk.
Thus humanization of animal milk also involves reducing of the l content.
Preparation of ts suitable for use in infant nutrition typically involves blending of
s individually purifled components in the appropriate , either wet or dry. Current
manufacturing processes require multiple dairy ingredients from intermediate suppliers,
including skim milk or a concentrate thereof (including skim milk powder), demineralised
whey or a trate thereof ding demineralised whey powder), whey protein
concentrates or isolates (normally as powders), and pure grade lactose (typically in powder
form) to formulate a nutritionally balanced infant formula.
WO 96/08155 describes a process for treating skim milk for the manufacture of cheese and
milk powders, wherein whey proteins are removed from skim milk by microflltration and
further treatment es ultraflltration.
US 5,503,865 discloses a process for treating skim milk, comprising microfiltration or
ultraflltration. The permeate f may be demineralised by for example ion exchange
and/or electrodialysis in order to make it suitable to be used in baby products.
US 4497836 ses a process wherein whey is subjected to ultraflltration, and the
permeate thereof is subjected to electrodialysis or ion exchange.
WO 3689 discloses a s wherein milk serum is subjected to ultraflltration, and
the te thereof is subjected to diaflltration. The ultraflltration retentate is combined
with the diaflltration retentate in the production of infant milk formulae, by mixing the
combined product with milk powder.
EP 1133238 describes a process wherein animal milk is subjected to microflltration through
a membrane having a porosity of 0.1 — 0.2 micrometer, after which the microfiltration
permeate comprising whey proteins is demineralised by electrodialysis. The l content
of the electrodialyzed microflltration te is very low, and subsequent fortif1cation with
minerals and trace elements is required to obtain an infant formula.
Summary of the invention
It is an object of the present invention to provide an improved process for preparing or
obtaining a dry milk formula wherein the amount of filtration and tion steps are
reduced compared to existing methods, problems related to ne fouling are reduced
and yield in obtaining lactose or milk proteins is improved. This object, wholly or in part, is
2O solved by the present invention according to the appended .
In general, the present invention relates to a process for obtaining a dry milk formula in
which more optimal use is made of filtration and separation technologies. In a preferred
embodiment, the present invention relates to a s for obtaining a dry milk formula,
preferably for obtaining a dry milk formula that can be further processed into an infant milk
formula or a dry milk infant formula (for human infants). Preferably, the process of the
present invention involves ultraflltration of animal skim milk and ultraflltration of animal
whey followed by mixing of the ultraflltration retentates, which are enriched in milk
proteins and whey ns respectively. Adding animal whey to animal skim milk alters the
protein composition of the skim milk, thereby humanizing the skim milk to more le
the n composition of human milk. Both animal skim milk and animal whey contain
polyvalent ions, the contents of which are reduced in order to make the combination of
animal skim milk and animal whey suitable as dry milk formulation for human consumption
or as a nutritional formulation for feeding human infants. In a red embodiment, also
monovalent ions are removed from the UF te and/or the UF retentate to sufficiently
low levels such that the dry milk formula is adapted for feeding human infants. Thus,
broadly worded, the present invention relates to a process for obtaining a dry milk formula
comprising the steps of ultraf11trating of animal skim milk and animal whey, removing
lent ions from at least one UF permeate, and combining the softened UF permeate
with the UF retentate followed by a drying step to obtain the dry milk formula.
The s ing to the invention employs ultraflltration for fractioning of casein and
whey proteins from lower molecular weight animal skim milk and animal whey tuents
(e.g. soluble salts, lactose, non-protein nitrogen (NPN), organic acids). As such, neither the
animal skim milk nor the whey require r softening or removal of monovalent ions to
the extent which is ordinarily done in the art, in order to reduce the soluble salts content to a
desirably low level, preferably sufficiently low for infant nutrition preparation. The process
according to the invention circumvents the need for including ively softened or
demineralized whey proteins or extensive softening or demineralization of liquid whey
protein streams, or the need for externally adding large amounts of dry lline lactose for
the cture of dry milk powder suitable for infant nutrition preparation, by employing
ultraflltration of animal skim milk and animal whey which are combined in a preferred ratio
to ze animal skim milk.
The lactose that is removed from both the animal skim milk and the animal whey as
ultraflltration permeate is subjected to polyvalent ion removal and preferably monovalent
ion removal, and used in the resulting dry milk formula. As such, the mineral content of the
resulting formulation can be adapted to sufficiently low levels to enable infant nutrition
preparation according to regulatory bodies (e.g. EU directive 2006/l4l/EC, US Food and
Drug Administration 21 CFR Ch 1 part 107).
Consequently, the t invention relates to a process for obtaining a dry milk formula,
comprising the steps of:
(a-i) ultraflltration (UF) of an animal skim milk composition comprising 70 — 90 wt%
casein and 10 — 30 wt% whey proteins, based on total protein, and
(a-ii) ultraflltration of an animal whey composition comprising 0 — 25 wt% casein and 75 —
100 wt% whey proteins, based on total protein; or
(a-iii) ultraflltration of a mixture of the compositions of (a-i) and (a-ii);
(b) preferably combining ofthe UF ate originating from step (a-i) with the UF
retentate ating from step (a-ii);
(C) removing polyvalent ions from the UF te originating from step (a-i) and/or
(a-ii) or (a-iii) to obtain at least one softened UF permeate;
(d) combining the at least one softened UF permeate originating from step (c) with a UF
retentate originating from step (a-i) and/or ; or (a-iii) or (b) to obtain a combined
product; and
drying the combined product originating from step (d) to obtain a dry milk formula;
and/or
drying any UF retentate originating from step (a-i) and/or (a-ii) or (a-iii) or (b) which
is not ed in step (d); and drying any of the softened UF permeates originating
from step (c) which is not combined in step ((1), followed by combining the dried UF
retentate with the dried softened UF permeate to obtain a dry milk formula.
In another aspect; the present ion relates to a modular system for carrying out the
process according to the invention; comprising:
2O (1) an ultraflltration module; comprising
(1a) an inlet for ing a first liquid composition as meant herein and/or a
second liquid composition as meant herein; or a mixture thereof; to a first
side of an lltration membrane;
(lb) the ultraflltration membrane;
(lc) a first outlet for discharging an ultraflltration retentate (UFR) from the first
side of the ultraflltration membrane; and
(1d) a second outlet for discharging an ultraflltration permeate (UFP) from the
second side of the ultraflltration membrane;
(2) a polyvalent ion removal module; comprising
(2a) an inlet for receiving the UFP originating from the lltration module
(1),
(2b) means for removing polyvalent ions; and
(2c) an outlet for discharging a softened UFP;
W0 2014/163493
(3) at least one mixing module, comprising
(3 a) a first inlet for receiving the softened UFP originating from the polyvalent
ion removal module (2),
(3bl) a second inlet for receiving the first liquid ition or an UFR of the
first liquid composition and a third inlet for receiving the second liquid
composition or an UFR of the second liquid, or
(3b2) a second inlet for receiving the mixture of the first liquid composition and
the second liquid composition or an UFR of the first liquid composition
and an UFR ofthe second liquid composition, and
(3c) an outlet for discharging a recombined product, and
(4) a drying module, comprising
(4al) a first inlet for receiving the UFR originating from the ultrafiltration
module (1) and a second inlet for ing the softened UFP originating
from the polyvalent ion removal module (2), or
(4a2) an inlet for receiving the recombined product originating from the mixing
module (3),
(4b) drying means, and
(40) an outlet for discharging a dried ition, wherein the first liquid composition is
an animal skim milk composition comprising 70 — 90 wt% casein and 10 — 30 wt%
2O whey ns, based on total protein, and wherein the second liquid composition is
an animal whey composition comprising 0 — 25 wt% casein and 75 — 100 wt% whey
ns, based on total protein.
List of preferred embodiments
The invention particularly pertains to:
l . A s for obtaining a dry milk formula, comprising the following steps:
(a-i) ultrafiltration (UF) of an animal skim milk composition comprising 70 — 90 wt%
casein and 10 — 30 wt% whey proteins, based on total protein, and
(a-ii) ltration of an animal whey composition comprising 0 — 25 wt% casein and 75 —
100 wt% whey proteins, based on total protein, or
(a-iii) ultrafiltration of a mixture of the compositions of (a-i) and (a-ii),
(b) preferably ing of the UF retentate originating from step (a-i) with the UF
retentate originating from step (a-ii),
(c) removing polyvalent ions from the UF permeate originating from step (a-i) and/or
(a-ii) or (a-iii) to obtain at least one softened UF permeate,
(d) combining the at least one softened UF permeate originating from step (c) with a UF
retentate originating from step (a-i) and/or (a-ii), or (a-iii) or (b) to obtain a combined
product; and
(e-i) drying the combined product originating from step (d) to obtain a dry milk formula,
and/or
(e-ii) drying any UF retentate originating from step (a-i) and/or (a-ii) or (a-iii) or (b) which
is not ed in step (d), and drying any of the softened UF permeates originating
from step (c) which is not combined in step (d), followed by combining the dried UF
ate with the dried softened UF permeate to obtain a dry milk formula.
2. The process according to 1, wherein the animal skim milk comprises 75 — 85 wt%
casein and 15 — 25 wt% whey proteins, based on total protein, preferably about 80 wt%
casein and about 20 wt% whey protein or the animal skim milk composition comprises or is
selected from animal skim milk, diluted animal skim milk, concentrated animal skim milk,
(optionally diluted) skim milk concentrate or reconstituted skim milk powder.
3. The s according to 1, n the animal whey composition comprises 0 — 20
wt% casein and 80 — 100 wt% whey proteins, based on total protein, preferably 0 — 10 wt%
casein and 90 — 100 wt% whey proteins, more preferably 0 — 5 wt% casein and 95 — 100
wt% whey proteins or the animal whey ition comprises or is selected from animal
whey, diluted animal whey, concentrated animal whey, (optionally diluted) animal whey
concentrate and tituted animal whey powder. Preferably, the animal whey is or
comprises sweet whey and/or acid whey, preferably the animal whey is sweet whey.
4. The process according to any one of l — 3, wherein a UF te originating from
step (a-i) and a UF permeate ating from step (a-ii) are combined prior to said removal
of polyvalent ions of step (c).
. The process according to any one of l — 4, wherein a UF retentate originating from
step (a-i) and/or (a-ii) is/are concentrated prior to the combining of step (b), (d) or drying of
step (e-i) and/or (e-ii), and/or a UF retentate ating from step (a-iii) and/or (b) is/are
concentrated prior to the combining of step (d) or drying of step (e-i) and/or (e-ii),
ably by nanoflltration.
6. The s according to any of 1-5, wherein the UF permeate originating from step
(a-i) is combined with a permeate ating from (a-ii) prior to polyvalent ion removal of
step (c), and preferably concentrated after polyvalent ion removal of step (c).
7. The process according to any of 1-6, wherein the softened UF te originating
from step (c) and/or the combined product of step (d) is/are concentrated, prior to the
combining of step (d) or the drying of step (e-i) and/or (e-ii).
8. The process according to any of 5-7, wherein concentration occurs by reverse
osmosis and/or nanofiltration.
9. The process ing to any one of l — 8, wherein polyvalent ion removal of step
(c) occurs by electrodialysis, ion exchange, lactose crystallization and/or salt precipitation,
more preferably by a combination of nanoflltration, salt precipitation, ultraflltration and
electrodialysis, most preferably following the sequence of nanoflltration, salt precipitation,
ultrafiltration and electrodialysis.
. The process according to any one of l — 9, wherein the softened UF permeate of step
(c) and/or the UF retentate originating from step (a-i) and/or (a-ii) or (a-iii) or (b) is/are
subjected to monovalent ion removal, preferably by electrodialysis, ltration, lactose
crystallization and/or salt precipitation.
11. The process according to any one of l — 10, wherein a UF retentate originating from
step (a-i) and/or (a-ii), or (a-iii) or (b) and/or a UF permeate originating from step (a-i)
and/or (a-ii) or ), and/or the softened UF permeate originating from step (c) or the
combined t of step (d) is/are heat-treated, preferably heat-sterilized by DSI, prior to
the drying of step (e-i) and/or (e-ii), preferably the combined product of step (d) is heat-
treated, preferably by DSI, prior to the drying of step (e-i), or preferably any of the UP
retentates of step (e-ii) and/or any of the softened UF permeates of step (e-ii) is heat-treated,
ably by DSI, prior to the drying of step (e-ii).
2014/050202
12. The process according to any one of 1 — 11, wherein drying of step (e-i) and/or (e-ii)
is by spray-drying.
13. The process ing to any one of 1 — 12, wherein the combined product
ating from step (d), the dried combined product of (e-i), and/or the dried UF retentate
of (e-ii) which is combined with the dried softened UF permeate of (e-ii) in step (e-ii) is
further sed into a nutritional product for providing nutrition to infants. Preferably, to
the combined product originating from step (d) is/are added suitable amounts of fat or oils,
dietary fiber, optionally additional lactose, vitamins and optionally onal minerals.
14. The process according to any one of 1 — 13, wherein the animal skim milk
composition and animal whey composition of step (a-iii) or the UF retentates originating
from step (a-i) and (a-ii) are combined in such a ratio that a product is obtained having a
:whey protein weight ratio of between 75:25 to 30:70, preferably between 64:36 to
36:64, more preferably 60:40 to 40:60 or about 50:50.
. The process according to any one of 1 — 13, wherein the mixture of the animal skim milk
composition and animal whey composition of step (a-iii) or the combined UF retentate of
step (b), or the combined product of step (d), the dry milk formula of (e-i) or the dry milk
formula of (e-ii) has a casein:whey protein weight ratio of between 75:25 and 30:70, more
preferably between 70:30 and 35:65, most preferably between 64:36 and 36:64 or about
50:50.
16. The process according to any one of 1 — 15, n the at least one softened UF
permeate of step (c) is obtained in a single polyvalent ion removal step or treatment.
17. The process according to any one of 1 — 16, wherein any UF retentate originating from
step (a-i) and/or , or step (a-iii) or step (b) is ted to a maXimum of two or
preferably only one concentration and/or lent ion removal step and preferably to one
or no polyvalent ion removal step before being subjected to the (e-i) or (e-ii) drying step.
18. The process according to any one of 1-7, n a UF permeate ating from step
(a-i) and a UF permeate originating from step (a-ii) are combined prior to said combining in
step (d), or preferably combined prior to the removal of polyvalent ions of step (c).
19. The process according to any one of 1 — 18, wherein the UF permeate originating from
step (a-i) and the UF permeate originating from step (a-ii) are combined in a volume ratio of
between 10:1 and 1:20, preferably 5:1 and 1:15, more preferably 1:1 and 1:10, most
preferably between 1:2 and 1:6.
20. The process according to any one of 1 — 19, wherein the mixture of step (a-iii) is
obtained by combining the animal skim milk composition and the animal whey composition
in a volume ratio of between 10:1 and 1:10, ably 6:1 and 1:6, more preferably 3:1 and
1:3 or wherein the combining in step (b) comprises ing the UF permeate originating
from step (a-i) with the UF permeate originating from step (a-ii) in a volume ratio of
between 10:1 and 1:10, preferably 6:1 and 1:6, more preferably 3:1 and 1:3.
21. The process according to any one of 1 — 20, wherein the UF retentate ating from
step (a-i), , (a-iii) and (b) are enriched for casein and whey proteins compared to the
first animal skim milk and second animal whey compositions, and/or the UF permeate
originating from step (a-i), (a-ii) and (a-iii) is enriched for lactose compared to the first
animal skim milk and second animal whey compositions.
22. The process according to any one of 1 — 21, wherein the ultraf11tration, polyvalent ion
removal step, monovalent ion removal step, any concentration step and/or any combining
step is performed at a temperature below 40 0C, more preferably between 3 oC and 30 oC
even more ably n 5 oC and 20 oC, most preferably between 8 and 12 oC. Higher
temperatures may increase the risk of spoilage of the dairy products, and lower temperatures
may give rise to freezing of the liquid streams, which are both undesirable.
23. The process according to any one of 1 — 22, n the process operates with 500 —
2500 kg, more preferably 800 — 1800 kg, most preferably 1000 — 1400 kg dry matter of the
animal skim milk composition incoming per hour.
24. The process ing to any one of 1 — 23, wherein the process according to the
invention operates with 1500 — 5000 kg, more preferably 2200 — 4000 kg, most preferably
2600 — 3000 kg dry matter of the animal whey composition, incoming per hour.
. The process according to any one of 1 — 24, wherein the process according to the
invention preferably es with 750 — 4000 kg, more preferably 1000 — 3000 kg, most
preferably 1500 — 2000 kg UF ate obtained per hour from the ultraf11tration of (a-i) and
(a-ii) or (a-iii).
26. The process according to any one of 1 — 25, wherein the process according to the
invention preferably operates with 1000 — 5000 kg, more ably 1500 — 4000 kg, most
preferably 2000 — 2500 kg UF permeate obtained per hour from the ultraf11tration of (a-i)
and (a-ii) or (a-iii).
27. The process according to any one of 1 — 26, wherein the 11tration of step (a-i) is
operated using a volume concentration factor of 1.5 — 6, preferably 1.7 to 4, more ably
1.8 to 3, most preferably about 2, and the ultraf11tration of step (a-ii) is operated using a
volume concentration factor of 2 — 15, preferably 3 - 10, more preferably 4 — 7, most
preferably about 5 and the 11tration of step (aii-i) is operated using a volume
tration factor of 1.5 — 10, ably between 2 and 8, more preferably between 3 and
6, most preferably about 4.
28. The process according to any one of 1 — 27, wherein at least 10 or 20 wt% of the
polyvalent ions that are present in said UF permeate (on dry weight basis thereof) is
removed, preferably at least 50 wt%, 60 wt%, more preferably 70 wt% or at least 80 wt%,
most preferably at least 90 wt%.
29. The process according to any one of 1 — 28, wherein monovalent ion removal comprises
removal of at least 10 or 20 wt% (on dry weight basis) of the monovalent ions from the
composition which was subjected to a monovalent ion removal step, more preferably at least
wt% or 50 wt%, most preferably at least 60 wt%.
2014/050202
. The s according to any one of l — 29, wherein the mixture of (a-iii) comprises a
casein:whey protein ratio of between 75:25 and 30:70, more preferably between 70:30 and
:65, most preferably between 64:36 and 36:64 or about 50:50.
Detailed description of the invention
Present day manufacturers of dry milk (infant) nutritional compositions largely rely on
supply and use of highly purified ingredients, such as purif1ed lactose, demineralized whey
proteins and minerals, to produce said compositions by mixing these sourced ingredients.
The present inventors have designed a process for treating animal skim milk and animal
whey for manufacturing dry dairy products, in particular dry milk formulations, which
largely circumvents buying such high-grade, pure ingredients from third parties.
The s of the t invention has several advantages over existing methods of
producing dry milk ae, e. g. the loss in lactose yield and whey during the processing of
skim milk and whey is reduced (e.g. during conventional demineralization of whey and
crystallization of lactose), cations related to fouling of membranes and tion of
protein material are reduced, the use of (externally added) chemicals is d and waste
water may be recycled in the s to a large extent. As such, the amount of waste and
waste streams is reduced compared to the conventional process. In addition, the need for
energy consuming drying, softening and demineralization steps is d. More in
particular, whereas lactose yield in conventional purification methods for the production of
dairy products lies around 83-85%, the lactose yield can be improved to over 90% in the
process of the present invention. Hence, the process according to the invention has a lower
environmental impact compared to the conventional process for producing dairy ts
such as dry formulae or milk powders, in particular nutritional products for feeding infants.
The process according to the invention employs two incoming liquid compositions (i.e. step
(a-i) and (a-ii)), the first thereof is an animal skim milk composition comprising 70 — 90
wt% casein and 10 — 30 wt% whey proteins, based on total n, and the second thereof is
an animal whey composition being comprising 0 — 25 wt% casein and 75 — 100 wt% whey
proteins, based on total protein. At one point in the process, the first and second liquid
compositions are combined or mixed. This combining or mixing may occur prior to
ultraflltration, such that the ultraflltration of step (a-iii) is performed on a mixture of the first
and the second liquid composition. Alternatively, the combining or mixing may occur after
11tration, such that ultraflltration is performed on the first liquid composition in step (a-
i) and the second liquid composition in step (a-ii).
In a first advantageous embodiment, the present invention relates to a process for obtaining a
dry milk formula, n preferably a single ultraflltration step is conducted, comprising
the following steps:
(a-iii) ultraf11tration of a mixture of an animal skim milk composition comprising 70 — 90
wt% casein and 10 — 30 wt% whey proteins, based on total protein, and an animal
whey composition comprising 0 — 25 wt% casein and 75 — 100 wt% whey proteins,
based on total protein,
(c) ng polyvalent ions from the UF permeate originating from step (a-iii) to
obtain a softened UF permeate,
(d) combining the softened UF permeate originating from step (c) with a UF retentate
originating from step (a-iii) to obtain a combined product, and
(e-i) drying the combined product originating from step (d) to obtain a dry milk formula.
In this first advantageous embodiment, the ratio of casein to whey protein can be influenced
by ing the volume ratio of the animal skim milk composition the animal whey
composition to be ultraf11trated. Thus, in this embodiment, preferably the animal skim milk
composition and animal whey composition of step (a-iii) are combined in such a ratio that a
UF retentate product is obtained having a casein:whey n weight ratio of n 75:25
to 30:70, preferably between 64:36 to 36:64, more preferably 60:40 to 40:60 or about 50:50.
Preferably, a volume ratio of n 10:1 and 1:10, preferably 6:1 and 1:6, more preferably
3 :1 and 1:3 of the animal skim milk ition to the animal whey composition is used to
achieve this end. This UF retentate product is preferably subjected to a concentration and/or
monovalent ion removal step before being combined with the softened permeate in step (d).
ably, this UF retentate product is subjected to a single concentration step (e.g. reverse
osmosis and/or nanof11tration) during which also monovalent ions are removed before being
combined with the ed permeate in step (d).
Furthermore, in this first advantageous embodiment, removing polyvalent ions in step (c) to
obtain a softened UF te, is followed by a monovalent ion removal step (preferably by
WO 63493
a nanofiltration and/or diaflltration step) before combining in step (d) takes place. This is
especially preferred when ion exchange against monovalent ions is used for softening. The
lactose enriched, softened UF permeate may be subjected to one, two or three nanoflltration
and/or reverse osmosis steps to remove sufficient monovalent ion amounts when preparing a
dry milk formulation usable for feeding a human infant.
rmore, in this first advantageous embodiment, ultrafiltration of step (aii-i) is operated
using a volume concentration factor of 1.5 — 10, preferably n 2 and 8, more
preferably between 3 and 6, most preferably about 4.
In a second ageous embodiment, the invention relates to a process for obtaining a dry
milk formula, comprising the following steps:
(a-i) ultraflltration (UF) of an animal skim milk composition comprising 70 — 90 wt%
casein and 10 — 30 wt% whey proteins, based on total protein, and
(a-ii) ultraflltration of an animal whey composition comprising 0 — 25 wt% casein and 75 —
100 wt% whey proteins, based on total protein,
(b) preferably combining of the UF retentate originating from step (a-i) with the UF
retentate originating from step (a-ii),
(c) removing polyvalent ions from the UF permeate originating from step (a-i) and/or
2O (a-ii) to obtain at least one softened UF permeate,
(d) ing the at least one softened UF permeate originating from step (c) with at
least a UF retentate originating from step (a-i) and/or , or (b) to obtain a
combined product, and
(e-i) drying the combined product ating from step (d) to obtain a dry milk formula,
and/or
(e-ii) drying any UF retentate originating from step (a-i) and/or (a-ii) or (b) which is not
combined in step (d), and drying any of the softened UF permeates originating from step (c)
which is not combined in step (d), followed by combining the dried UF ate with the
dried softened UF permeate to obtain a dry milk formula.
In this second advantageous ment, the ratio of casein to whey n can be
influenced by selecting the volume ratio ofUF retentate originating from (a-i) and (a-ii),
either in step (b) or in step (d) or (e-ii). Thus, in this embodiment, preferably the UF
retentates ating from step (a-i) and (a-ii) are combined in such a ratio that a UF
retentate product is obtained having a casein:whey protein weight ratio of between 75:25 to
:70, preferably between 64:36 to 36:64, more preferably 60:40 to 40:60 or about 50:50.
Preferably, a volume ratio of between 10:1 and 1:10, preferably 6:1 and 1:6, more preferably
3 :1 and 1:3 of the UP retentates originating from step (a-i) and (a-ii) is used to achieve this
goal. The UF retentates originating from (a-i) and/or (a-ii) or (b) is/are preferably ted
to a tration and/or monovalent ion removal step before being combined with the
softened te in step (d). Preferably, any or all of these UF retentates are subjected to a
single concentration step (e.g. reverse osmosis and/or nanoflltration) during which also
monovalent ions are removed before being combined with the softened permeate in step (d).
Furthermore, in this second advantageous embodiment, removing polyvalent ions in step (c)
to obtain a softened UF permeate, is followed by a monovalent ion removal step (preferably
by a nanof11tration and/or diaflltration step) before combining in step (d) takes place. This is
especially preferred when ion ge against lent ions is used for softening. The
lactose enriched, softened UF permeate may be subjected to one, two or three nanoflltration
and/or reverse osmosis steps to remove sufficient monovalent ion amounts when ing a
dry milk formulation usable for feeding a human .
In a preferred version of this second advantageous embodiment, the UP retentates
originating from (a-i) and (a-ii) are (individually or separately) subjected to a concentration
and/or monovalent ion removal step prior to ing in step (b). Next, the thus treated
and combined UF retentate is combined in step (d) with a softened permeate originating
from (c). Preferably, the softening in this step (c) involves removing polyvalent ions from a
single UF permeate originating from combining the permeates originating from (a-i) and (a-
ii) to obtain one softened UF permeate.
In an ative , a process for treating animal skim milk and animal whey is
mentioned , sing:
(a) ultraflltration (UF) of a mixture of animal skim milk and animal whey (sweet and/or
acid whey) over an ultraflltration membrane having a molecular weight cut-off of 2.5 — 25
kDa using a volume concentration factor of 1.5 — 10, preferably between 2 and 8, more
preferably between 3 and 6, most preferably about 4, and obtaining a retentate and a
permeate. Optionally, polyvalent ions are removed from the UF permeate originating from
step (a) after which the softened UF permeate is preferably subjected to a concentration
and/or monovalent ion removal step. Optionally, also the UF retentate is subjected to a
concentration and/or monovalent ion removal step. Preferably, the softened UF permeate,
which preferably also has undergone monovalent ion removal, is mixed with the UP
retentate originating from step (a), which UF retentate may or may not have undergone
concentration and/or monovalent ion removal, to obtain a mixture. Said e is
preferably dried to a dry milk formula. Preferably, the e of animal skim milk and
animal whey comprises a casein:whey protein ratio of between 75:25 and 30:70, more
preferably between 70:30 and 35:65, most preferably between 64:36 and 36:64 or about
50:50.
Definitions
The term "animal whey" herein refers to the liquid by-product obtained from the cheese-
making industry. The term “whey protein” refers to proteins that are present in said animal
whey, such as sweet whey or acid whey. Typically, whey proteins include, i.a. beta-
lactoglobulin, alpha-lactalbumin, bovine serum albumin, immunoglobulins, lactoferrin,
lactoperoxidase and/or glycomacroprotein.
The term “sweet whey” herein refers to the liquid (whey protein containing) by-product of
the cheese manufacture industry which makes use of enzymatic cheese curd formation (e. g.
based on casein precipitation using rennet), which material is readily accessible in the
commercial market. lly, whey proteins present in sweet whey include, i.a. beta-
lobulin, alpha-lactalbumin, bovine serum albumin, immunoglobulins, lactoferrin,
lactoperoxidase and glycomacroprotein
Conversely, the term “acid whey” herein refers to the liquid (whey n containing) by-
t of the cheese cture industry which makes use of (edible) acids for cheese
curd formation (e.g. based on casein precipitation using acids such as citric acid), which
al is y accessible in the commercial market. Typically, whey proteins present in
acid whey include, i.a. actoglobulin, alpha-lactalbumin, bovine serum albumin,
globulins, lactoferrin and lactoperoxidase
The term n" herein refers to casein or caseinate proteins as found in animal skim milk,
such as bovine skim milk, more in particular cows' skim milk. Preferably, casein or
caseinate is in substantially intact, non-hydrolyzed form.
By a “UF retentate originating from” is meant the liquid retentate composition that is
(directly) obtained from ultraflltration steps (a-i), (a-ii) and (a-iii). The term also refers to the
UF retentates that are conveyed as (liquid) compositions from the ultraflltration step to the
optional combining step (b) or the ing with a softened UF te in step (d) to
obtain the combined permeate/retentate product or drying in step (e-ii). Irrespective of
whether between the obtaining of the UF retentate from step (a-i), (a-ii) or (a-iii) and the
combining in step (d) or drying in step (e-ii), the UF retentate is ted to a concentration
step, such as reverse osmosis or nanoflltration, the term UF retentate still applies to this UF
fraction. Thus, the term UF retentate is meant to denote the (protein enriched) fraction that is
processed ing to the steps of the invention from the ultraflltration step up to the point
where it is (re)combined with a UF permeate.
rly, the term “UF permeate originating from” herein means the liquid permeate
composition that is (directly) obtained from ultraflltration steps (a-i), (a-ii) and (a-iii). The
term also refers to the UF permeates that are conveyed as (liquid) compositions from the
ultraflltration step to the polyvalent ion removal module, optional means for removing
monovalent ions and/or optional concentration module to eventually obtain the combined
te/retentate product of (d) or to the drying module for drying in step (e-ii).
Irrespective of whether between the obtaining of the UF permeate from step (a-i), (a-ii) or
) and the combining in step (d) or drying in step (e-ii), the UF permeate is subjected to a
processing step (e.g. a polyvalent ion removal step, a concentration step, reverse osmosis
and/or nanoflltration), within the context of the present invention the term UF permeate still
applies to this UF on. Thus, the term UF permeate is meant to denote the (lactose
ed) fraction that is processed according to the steps of the invention from the
ultraflltration step up to the point where it is mbined with a UF retentate.
As used herein, the term alent ions” refers to ions having a positive or negative
charge of two or more. More in particular, this term refers to Mg2+, Ca2+ and polyvalent
phosphate anions (e.g. HPO42', PO43) The term “monovalent ions” refers to ions having a
positive or negative charge of one, in particular Na+, K+, Cl'.
The term al of polyvalent ions” means that said polyvalent ions are removed from
the UP te composition which is ted to the polyvalent ion removal step (step
(c)). Preferably, the term “removal of lent ions” indicates that at least 10 or 20 wt% of
the polyvalent ions that are present in said UF permeate (on dry weight basis thereof) is
removed, preferably at least 50 wt%, 60 wt%, more preferably 70 wt% or at least 80 wt%,
most preferably at least 90 wt%. The weight percentage (wt%) of polyvalent ion removal is
determined by comparing the total weight of polyvalent ions present after step (c) to the total
weight of polyvalent ions present prior to step (c). Likewise, the term “softening” is used to
denote the removal of polyvalent ions. Hence, herein “softening” and “removal of
polyvalent ions” is used interchangeably. Analogously, the term “softened” is used to refer
to a composition from which polyvalent ions have been removed. Preferably, the term
“softened” means that at least 10 or 20 wt% (on dry weight basis) of the polyvalent ions is
removed from the ition by polyvalent ion removal, preferably at least 50 wt% or 60
wt%, more preferably 70 wt% or 80 wt%, most preferably at least 90 wt%. “Signif1cant
polyvalent ion removal” denotes the removal of at least 70 wt% of the polyvalent ions,
preferably at least 85 wt%, more preferably at least 95 wt% or even at least 99 wt% of the
polyvalent ions. Polyvalent ion l or softening may be accompanied with monovalent
ion l, either in the same step or in a separate step. Preferably, polyvalent ion removal
refers to removal of at least or all of calcium, magnesium and/or phosphate s to the
extent as defined in this paragraph.
The term “removal of monovalent ions” means that said monovalent ions are removed from
the composition which is subjected to the monovalent ion removal step (preferably a
softened UF permeate and/or any UF retentate). In case not indicated otherwise, preferably
at least 10 or 20 wt% (on dry weight basis) of the monovalent ions is removed from the
ition which was subjected to a lent ion removal step, more preferably at least
35 wt% or 50 wt%, most preferably at least 60 wt%. Removal of monovalent ions is
particularly preferred in case the process according to the ion aims to manufacture dry
powder formulations intended for use as infant nutrition. “Signif1cant monovalent ion
removal” denotes the removal of at least 70 wt% of the monovalent ions, preferably at least
85 wt%, more preferably at least 95 wt% or even at least 99 wt% of the monovalent ions.
Preferably, monovalent ion removal refers to removal of at least or all of sodium, potassium
and/or chloride to the extent as defined in this paragraph.
The “total solid content” of a liquid composition denotes the weight percentage of solids
present in the composition, based on the total weight of the composition. Solids include all
non-volatiles, typically everything except water.
The term “enriched” herein refers to the situation wherein the amount of a certain
constituent in a (liquid) composition (as wt% based on dry weight) is higher after a s
step, when compared to the t of the same ingredient in the (liquid) composition before
said process step. Preferably, the dry weight percentage of an ingredient that is ed has
a content in a stream discharged from the process step of at least 110 %, more preferably at
least 125%, most ably at least 150 %, based on the dry weight percentage of said
ingredient in the incoming stream of said process step. Exemplary is the ultraflltration of
animal skim milk, wherein the milk proteins are ed in the retentate while water and
small s permeate through the ultraflltration membrane. As such, the UF retentate is
enriched in milk proteins, as the t of milk proteins in the retentate, as wt% based on
dry weight of the composition, is sed compared to the wt% of milk proteins in skim
milk. Likewise, the UF permeate is enriched in small solutes (preferably lactose), as the
amount of proteins is significantly reduced in the permeate, and e constitutes by far the
largest part of the dry weight of the permeate.
The term “dry milk formula” refers to a dry powder which at least comprises milk proteins,
in particular casein and whey, and minerals which is obtained by drying animal skim milk
and animal whey and is intended for human consumption. As such, the milk formula is dried
and has a water content of between 0.5 and 5 wt%, based on total weight of the formula,
preferably n 1 and 4 wt% or 1.5 and 3.5 wt%. The term “dry milk infant formula”
herein refers to a dry milk formula which is adapted for feeding human infants.
The term “volume concentration factor” or “VCF” is the factor at which a liquid
composition is concentrated upon flltration, i.e. the total volume of the incoming stream
prior to filtration divided by the total volume of the retentate after ion, irrespective of
the total solid content. Thus, when 5 L of a liquid composition is fractionated over an
ultrafiltration membrane into a permeate of 4 L and a retentate of l L, this UF process
operates with a VCF of 5/1 = 5.
The term “about” indicates a variation (plus and minus) of 10 % of the given value, more
preferably 5%.
First liquid composition (animal skim milk) and second liquid composition (animal whey)
The process according to the invention uses at least two sources of milk protein, lactose and
minerals, the first being a (liquid) animal skim milk composition comprising 70 — 90 wt%
casein and 10 — 30 wt% whey proteins, based on total protein and the second being a (liquid)
animal whey ition comprising 0 — 25 wt% casein and 75 — 100 wt% whey proteins,
based on total protein.
The first liquid composition is an animal skim milk ition which comprises milk
proteins and lactose. It comprises s of minerals that are typical for animal skim milk
(in the form of monovalent and polyvalent ions). The protein fraction of the first liquid
composition comprises 70 — 90 wt% casein and 10 — 30 wt% whey proteins, preferably 75 —
85 wt% casein and 15 — 25 wt% whey protein, most preferably 80:20 wt% casein to whey
n, based on dry total weight of the protein fraction. Preferably, the first liquid
composition comprises 20 — 60 wt% protein, more preferably 25 — 50 wt% n based on
total dry weight of the first liquid composition. Preferably, the first liquid composition
comprises 25 — 75 wt% e, more preferably 40 — 60 wt% lactose, based on total dry
weight of the first liquid composition. Preferably, the first liquid composition comprises 3 —
15 wt% minerals, more preferably 5 — 10 wt% minerals, based on total dry weight of the
first liquid composition. Preferably, the first liquid ition comprises 25 — 75 wt%
monovalent ions, more preferably 40 — 70 wt% monovalent ions, and 25 — 75 wt%
polyvalent ions, more preferably 30 — 60 wt% polyvalent ions, based on total dry weight of
the minerals. Preferably, the first liquid composition has a total solid content between 3 and
15 %, more preferably between 6 and 11 %, most ably between 7.5 and 10 %. The fat
content of the animal skim milk is typical for animal skim milk and lies well below that of
non-skim milk. In ular, the fat content lies below 3 wt% (g/100g animal skim milk),
preferably below 2 wt%, more ably below 1 wt%, most preferably below 0.5 wt%.
WO 63493
In an especially red embodiment, the first liquid composition comprises animal skim
milk or is animal skim milk. Animal skim milk (i.e. non-human skim milk), preferably from
bovine animals, and may be used as such, in diluted or concentrated form, as (optionally
diluted) skim milk trate or as reconstituted skim milk powder. Most preferably, the
first liquid composition is cows’ skim milk. The animal skim milk may be pretreated before
it is subjected to the process according to the invention. Such pre-treatment comprises or
consists of a heat-treatment step (e.g. pasteurization) and/or tion step to reduce the
bacterial load of the animal skim milk. Preferably, the animal skim milk is not pre-treated
with the aim to change the mineral content or e thereof In ular, the animal skim
milk is preferably not (significantly) softened or subjected to monovalent ion removal before
it enters the present ultraf11tration process.
The second liquid is an animal whey composition which comprises n, lactose and
amounts of minerals that are typical for animal whey (in the form of monovalent and
polyvalent ions). The protein fraction of the liquid animal whey composition comprises 0 —
wt% casein and 75 — 100 wt% whey proteins, preferably 0 — 10 wt% casein and 90 — 100
wt% whey protein, most preferably 0 — 5 wt% casein and 95 — 100 wt% whey protein, based
on dry total weight of the protein fraction. Preferably, the animal whey composition
2O comprises 5 — 40 wt% protein, more ably 7 — 17 wt% protein based on total dry weight
of the second liquid composition. Preferably, the animal whey composition comprises 40 —
90 wt% lactose, more preferably 60 — 80 wt% lactose, based on total dry weight of the
second liquid composition. Preferably, the animal whey composition comprises 3 — 15 wt%
minerals, more preferably 6 — 12 wt% ls, based on total dry weight of the second
liquid composition. ably, the animal whey composition comprises 40 — 90 wt%
monovalent ions, more preferably 60 — 85 wt% monovalent ions, and 10 — 60 wt%
polyvalent ions, more preferably 15 — 40 wt% polyvalent ions, based on total dry weight of
the minerals. Preferably, the animal whey composition has a total solid content n 1
and 15 %, more preferably between 3 and 10 %, most preferably between 4 and 8 %.
The animal whey is derived from making cheese wherein any non-human (skim) milk is
used, preferably from bovine skim milk, most preferably cows’ milk. Animal whey may be
used as such, in diluted or concentrated form, as (optionally diluted) animal whey
concentrate and as reconstituted animal whey from a powder. Both sweet whey and acid
whey are suitable as liquid animal whey composition for use in the invention. Most
ably, the second liquid composition is sweet whey. The animal whey as used may be
pretreated before it is subjected to an ultraflltration step of the process ing to the
invention. Pre-treatment of the animal whey comprises or consists of heat-treatment
(preferably pasteurization) and/or filtration to reduce the ial load of the animal whey.
Preferably, the animal whey is not pre-treated with the aim to change the mineral content or
profile thereof. In particular, the animal whey is not (significantly) softened or subjected to
monovalent ion removal before it enters the t process.
Any pretreatment of animal skim milk or animal whey is primarily not preferred from a cost
perspective: any such step is likely to increase the price of these liquid compositions, while
the process of the invention is designed such that it is capable of processing these liquid
compositions t any costly pretreatment step into a dry milk formulation.
Ullraflltralion (UF) step (cl-l), 1), (cl-iii)
In the process according to the invention, the first animal skim milk composition and the
second animal whey composition are subjected to a UF step: (a-i) and (a-ii) or (a-iii). Herein
water and small solutes can permeate through the membrane to end up in the UF permeate
2O (UFP), while the UF retentate (UFR) comprises substantially all protein, which can be stated
to be enriched in proteins. Small molecules which are able to permeate through the UP
membrane include lactose, NPN, monovalent ions and polyvalent ions. Thus, the UFP can
be stated to be enriched in lactose.
The ultraflltration of step (a) may employ any UF membrane known in the art, including
ceramic membranes, tubular and organic spiral wound membranes, preferably the UP
membrane is an organic spiral wound ne. The UF ne has a molecular weight
cut-off (MWCO) of that enables proteins (e.g. whey proteins and casein) to remain in the
retentate, and allow small solutes (e. g. solutes having a molecular weight of at most 25 kDa,
preferably at most 10 kDa) to permeate through the membrane. Preferably, the molecular
weight cut-off is at most 25 kDa, more ably at most 10 kDa, and ably of at least
2.5 kDa, more preferably at least 5 kDa.
In a preferred embodiment, the lltration involves steps (a-i) and (a-ii), which are
separately performed on the first liquid composition and the second liquid ition
respectively, and preferably followed by combining of the UF retentates originating
thereform in step (b). Said combining or mixing in step (b) provides a (combined) UF
retentate of which the protein composition is altered in the sense that the casein to whey
n weight ratio is reduced. The (weight or volume) ratio in which the UF retentates
originating from steps (a-i) and (a-ii) are ed is dependent on the exact protein
composition of the incoming first liquid composition but is mainly determined by the
desired protein composition in the resulting UF retentate and/or the resulting dry milk
formula. The skilled person is able to determine the protein composition and concentration
ofthe incoming first liquid composition or the UP retentate thereof by methods known in the
art, e.g. by the method ing to FT001/IDF 20-3 (for total protein, N * 6.38), IDF29-
l/ISOl7997-l:2004 (for casein) and FT003 (for whey, NCN, non-casein nitrogen * 6.38).
The exact protein composition of incoming first liquid composition (animal skim milk), or
the UF retentate thereof, may vary between ent s, but even skim milk from the
same animal (e.g. cow) may exhibit limited seasonal variations. In a particularly preferred
embodiment, the dry milk formula is further processed into a nutritional product for human
s such as infant ae, weaning infant formulae, follow up milk or formulae,
g-up milk or toddler milk. In this respect, the resulting weight ratio of casein:whey
protein after mixing is preferably n 75:25 and 30:70, more preferably between 70:30
and 35:65, most ably between 64:36 and 36:64 or about 50:50.
In case ultraflltration is by step (a-i) and (a-ii), mixing of the UF retentate originating
therefrom may be performed on liquid streams thus giving a liquid mixture. Alternatively,
the UF retentate originating from step (a-i) and (a-ii) is subjected to drying of step (e-i) and
(e-ii) prior to mixing, and a liquid composition and a solid composition are mixed (e. g. by
dissolving the solid in the liquid) to obtain a liquid mixture, or two solid compositions,
preferably powders, are mixed (e.g. by dry blending) to obtain a dry mixture, preferably a
. In case drying is performed prior to mixing, it is preferred that both UF retentates
originating from (a-i) and (a-ii) are subjected to the drying of step (e-i) and (e-ii) prior to
mixing, and the resulting solids are dry blended. Preferably, the dried compositions are
powders. In an especially preferred ment, both streams are liquid during mixing and
the drying of step (e-i) and (e-ii) is performed on the liquid mixture, after mixing of the UF
retentate originating from step (a-i) and (a-ii).
In another preferred embodiment, the UP of step ) is performed on a mixture of the
(first) liquid animal skim milk composition and the (second) liquid animal whey
composition of the present invention. Mixing of the first liquid composition with the second
liquid composition thus is performed prior to ultrafiltration. This mixing of the first liquid
composition with the second liquid composition enables the tion of the protein
composition of the first liquid composition, in particular the alteration of the protein
composition of animal skim milk. The (weight or ) ratio in which the second and the
first liquid composition are mixed is dependent on the exact protein composition of the
incoming first liquid composition but is mainly determined by the desired protein
composition in the resulting UF ate, and preferably the resulting dry milk formula.
Both in case the first liquid composition and the second liquid composition are subjected to
ultrafiltration of step (a-i) and (a-ii) separately, or UP is by step ), the UP retentates
originating from step (a-i), (a-ii) and/or (a-iii) may undergo further processing steps, either
prior to the mixing of the UP retentates originating from (a-i) and/or (a-ii) or the UP
retentate originating from (a-iii). Such optional further processing steps include, and are
preferably limited to, trating the liquid composition (i.e. increasing the protein/water
weight ratio, e.g. via (partial) evaporation or filtration techniques such as nanofiltration or
reverse osmosis), heat-treatment (e.g. pasteurization (such as HTST, ESL or UHT) or
sterilization (dry heat or moist heat)) and/or supplementation of additional water or other
components. Preferably, the UP retentate originating from (a-i) and/or (a-ii) are subjected to
a concentration step, prior to or after mixing of the UP ates in step (b), preferably
using nanofiltration, optionally enhanced with ration, and/or reverse osmosis.
Performing the concentration step on the individual UF retentates has the advantage that
more flexibility and fine-tuning is d in the process of the invention. Preferably, the
UP retentate originating from ) or (b) is subjected to a concentration step, ably
using nanofiltration, optionally enhanced with ration, and/or reverse osmosis. In an
optional embodiment, the drying of step (e-i) or (e-ii) occurs on each of the UP retentates
originating from UF of the first and second liquid composition separately, prior to .
In an especially preferred embodiment, the further processing steps that may be performed
on the UF retentates of (a-i) and (a-ii) prior to mixing thereof do not include any polyvalent
ion removal step or any step that fractionates the proteins.
Mixing (such as in step (b))
Mixing of the first liquid composition with the second liquid ition prior to (a-iii), or
combining of the UF retentates originating from (a-i) and (a-ii) in step (b) may be
accomplished by any means known in the art, such as “in pipe” (i.e. by the joining of two
ng pipes into one single outgoing pipe), in a (balance) tank or vessel, in an agitated
vessel or by any industrial mixer or blender. In case two liquid streams are mixed, dynamic
mixing or static mixing may be employed. In case two dried streams (e. g. two powders) are
mixed, a dry blender such as a ribbon blender, a paddle blender, a tumble blender and a
vertical blender, may be employed. Preferably, the mixing step is performed on two liquid
streams, preferably “in pipe” or in a balance tank. The ratio in which the first animal skim
milk composition is mixed with the second animal whey composition prior to (a-iii), or
mixing of the UF retentate originating from (a-i) and (a-ii) in step (b) is conveniently
influenced by controlling the flow rate of the incoming compositions.
Polyvalenl ion removal (step (0))
Ultraflltration of the first animal skim milk composition and the second animal whey
composition in (a-i) and (a-ii), or of the mixture thereof (in step (a-iii)) affords at least one
ultraflltration permeate (UFP) comprising (or enriched in) lactose. At least one of the UF
permeates originating from step (a) is softened in step (c) to obtain at least one softened UF
permeate, which is subsequently combined in step (d) with any of the ates of the
ultraflltration of step (a). In step (c) of the process according to the ion, polyvalent
ions are d from any of the UF permeates originating from step (a). In case
ultraflltration is by step (a-i) and , two UF permeates are obtained. In case the
ultraflltration is by step (a-iii) on the e of the first liquid composition and the second
liquid composition, one UF permeate is obtained. Thus, at least one of the UF permeates
originating from UF of the first liquid composition and the UF permeate originating from
UF of the second liquid composition is subjected to the polyvalent ion l of step (c),
or the UF permeate originating from (a-iii) is subjected to the polyvalent ion removal of step
(c).
In case two UF permeates are obtained in the lltration of step (a-i) and (a-ii), the UF
permeates ating therefrom may be combined prior to step (c), or step (c) is performed
on at least one of the UP permeates, 1'.e. on only one of the UP tes or on each of the
UP permeates separately. In case two UF permeates are obtained from the ultraflltration of
step (a-i) and (a-ii), both UF permeates ating therefrom are subjected to the polyvalent
ion removal in step (c), preferably the UFPl and the UFP2 are combined prior to step (c)
into a single UF permeate such that one UF permeate is softened in (c).
The polyvalent ion removal of step (c) enables the removal of (significant) amounts of
polyvalent ions. Preferably at least 10 or 20 wt%, or preferably 50 wt%, more preferably at
least 70 wt% or at least 80 wt%, most ably at least 90 wt% of the polyvalent ions are
removed.. Thus, the softened UF permeate comprises at least 50 wt% less polyvalent ions,
preferably at least 70 wt% less, more preferably at least 80 wt% less, most preferably at least
90 wt% less polyvalent ions, when compared to the incoming UF permeate originating from
step (a).
Softening of at least one of the UP permeates originating from the UP of step (a-i) and/or (aii
) or (a-iii) is preferably accompanied with or followed by the l of monovalent ions.
Preferably, the monovalent ion removal step causes the removal of significant amounts of
monovalent ions. Preferably, at least 10 or 20 wt% of the monovalent ions are removed,
more ably at least 35 wt% or at least 50 wt%, most preferably at least 60 wt% of the
lent ions are removed. Removal of monovalent ions (such as from the at least one
UF permeate originating from step (c) and/or at least one or all of the UP retentates
originating from step (a-i) and/or (a-ii) or (a-iii) or (b)) is especially preferred in case the
dairy product ed by the process according to the invention is further processed into a
nutritional product suitable for infant nutrition.
Polyvalent ion removal and optionally monovalent ion removal may be accomplished using
any technique known in the art, such as electrodialysis, ion exchange, salt precipitation,
lactose crystallization, membrane filtration techniques such as nanofiltration, optionally
enhanced with diaflltration, or combinations thereof The preferred polyvalent ion removal
technique is ion exchange. In the context of the present invention, lent ion removal,
optionally combined with monovalent ion removal, also es the crystallisation of
lactose from a liquid UF permeate originating from step (a-i) and/or (a-ii) or (a-iii) and
simultaneously keeping (significant amounts of) the polyvalent ions and preferably
(significant amounts of) the monovalent ions in solution. The obtained crystalline lactose is
regarded to be a softened UF permeate in the context of the present invention, as it
originates from the UF of step (a) and has (significant amounts of) the polyvalent ions
removed.
The process of the invention generates at least one or two UF permeates (from (a-i) and (a-
ii)), or from (a-iii). In case two UF permeates are obtained, they are preferably combined
prior to being subjected to polyvalent ion removal (i.e. softening), which can be followed by
monovalent ion removal. In a more costly embodiment, the two UFP permeates of (a-i) and
(a-ii) are separately subjected to polyvalent ion removal and optionally monovalent ion
removal, to obtain two softened UF permeates which uently can be combined. Each
of the softened UF permeates may then be used in the ining of step (d), preferably
the softened UF te originating from (a-i) and the softened UF permeate originating
from (a-ii) are mixed prior to the combining of step (d) or they are aneously combined
during step (d). Each of the UP permeates originating from the UP of step (a-i) and/or (a-ii)
or ) may undergo further processing steps prior to being subjected to the polyvalent ion
l of step (c). Such optional further processing steps include, preferably are limited to,
concentrating the liquid stream (i.e. increasing the lactose/water weight ratio, e. g. via
al) evaporation or filtration techniques such as nanofiltration or reverse osmosis), heat-
treatment (e.g. pasteurization (such as HTST, ESL or UHT) or sterilization (dry heat or
moist heat)) and/or supplementation of additional water or other components. Concentration
may also be accomplished during the softening in step (c) or during the optional lent
ion removal, e. g. during nanofiltration, optionally enhanced with diafiltration.
It is preferred that removal of polyvalent ions of at least one (or ably all) of the UF
permeates originating from step (a-i) and/or (a-ii) or (a-iii) is performed by ion ge.
Preferably, this step is followed by subjecting the at least one or all of the softened UF
permeate to nanofiltration (NF) in order to trate it and also remove ficant
amounts of) monovalent ions rom. Using this sequence of steps, the softened UF
permeate from which (significant amounts) of monovalent ions are removed, is then
combined with any of the UP retentates in step (d) or dried and combined in step (e-ii).
During ion exchange, the polyvalent ions (e.g. Mg2+, Ca2+, PO43') are replaced by
monovalent ions (typically Na+, K+, Cl'), and during nanofiltration these monovalent ions
permeate through the nanoflltration membrane such that separation of lactose and
monovalent ions is effectuated. Preferably, nanoflltration is enhanced with diaflltration, i.e.
at least once an additional volume of water is added to the NF retentate, and the diluted NF
retentate is subjected to NF again. Conveniently, the NF permeate, comprising monovalent
ions, may be used to regenerate the ion exchange column(s).
It is especially preferred that removal of polyvalent ions of at least one (or preferably all) of
the UF permeates ating from step (a-i) and/or (a-ii) is performed by a combination of
steps comprising ltration, salt precipitation and precipitate removal. Preferably, this
combination of steps also comprises electrodialysis. More preferably, removal of polyvalent
ions is performed in the following order: ltration, salt precipitation and precipitate
removal. Preferably, the precipitate removal is followed by a further nanofiltration step
(preferably enhanced with diaflltration) or by electrodialysis, most preferably it is followed
by electrodialysis. The salt itation step is mainly aimed at removal of polyvalent ions,
in particular phosphate ions, such as m ate and ium phosphate, and can
be achieved by creating suitable conditions under which calcium ions precipitate from the
lactose-enriched liquid. These conditions e addition of a strong base, such as sodium
hydroxide, pH adjustment to a neutral pH, such as between 6 and 8, and increasing the
temperature to between 70 and 90 oC, followed by decreasing the temperature to a between
and 30 oC. Also calcium and magnesium levels will decrease under these precipitation
conditions. Subsequently, the precipitates may be removed by any technique known in the
art (e.g. tion, centrifugation). Especially suitable to remove the precipitates is an
ultrafiltration step. It is preferred that the resulting polyvalent ion-depleted UF permeate(s)
is/are r desalted in a further nanofiltration step and/or an odialysis step, most
preferably in an odialysis step. Any type of electrodialysis as known in the art may be
employed. The result is a lactose-enriched, softened UF permeate as ed to in step (c)
that can be ed in step (d) with a UF retentate originating from step (a-i) and/or (a-ii),
or (a-iii) or (b) to obtain a combined product.
Combining step (09
Any or all of the softened UF permeates originating from step (c) is/are combined in step (d)
with any of the UF retentates originating from step (a-i) and/or (a-ii) or (a-iii) to obtain a
combined product. Thus, (i) the ed UF permeate originating from (a-i) and/or (a-ii)
(either separate or combined, preferably combined), or (ii) the softened UF permeate
originating from (a-iii) is added to any of the UF ates originating from step (a-i) and/or
(a-ii) or (a-iii). Thus, the at least one softened UF permeate originating from step (c) is
ed with the UF retentate originating from (a-i) and/or (a-ii) or (a-iii) or step (b).
Each of the softened UF permeates comprises lactose. As the skilled person will appreciate,
the amount of any of the softened UF permeates that is to be recombined with any of the UP
retentates, may depend on the desired amount of lactose in the final dairy product, the
amount and purity of lactose in each of the softened UF tes originating from step (c)
that is subjected to the combination of step (d), and the amount of residual lactose present in
any of the UP ates originating from step (a). In a preferred embodiment, at least 70
wt%, preferably at least 80 wt%, more preferably at least 90 wt% or even at least 95 wt%,
most preferably at least 98 wt% of the lactose that is obtained in the UF permeate(s)
originating from step (a) is combined in step (c) with the UP retentates originating from step
(a). The lactose t in a liquid ition can readily be determined by skilled person,
e.g. enzymatically or by HPLC.
Each of the softened UF permeates and each of the UF retentates may undergo r
processing steps prior to the combining of step (d). The UF retentate ating from (a-i)
and/or (a-ii) or (a-iii) or step (b) may be subjected to further processing steps prior to
subjecting it to the combining of step (d). Such further processing steps include, preferably
are limited to, trating the liquid stream (i.e. increasing the protein/water weight ratio,
e.g. via (partial) evaporation or filtration techniques such as nanoflltration or reverse
osmosis), heat-treatment, e.g. pasteurization (such as HTST, ESL or UHT) or sterilization
(dry heat or moist heat)) and/or mentation of additional water or other components.
Preferably, the UF retentate originating from (a-i) and/or (a-ii) or (a-iii) or step (b) is
subjected to a concentration step after the ultraflltration of step (a) and prior to the
combining of step (d), preferably using nanoflltration, ally enhanced with diaflltration,
and/or reverse osmosis.
In an especially preferred embodiment, the UF ate originating from (a-i) and/or (a-ii)
or (a-iii) or step (b) is not subjected to any to polyvalent ion removal step after the
ultraflltration of step (a). ably, the UF retentate originating from (a-i) and/or (a-ii) or
(a-iii) or step (b) is not subjected to electrodialysis, ion exchange and salt itation. In an
optional embodiment, the drying of step (e-i) or (e-ii) occurs prior to combining of step (d)
and the drying of step (d). Prior to the combining of step (d), any of the softened UF
tes may undergo further processing steps. Such optional further processing steps
include, preferably are limited to, concentrating the liquid stream (i.e. increasing the
lactose/water weight ratio, e.g. via (partial) ation or filtration techniques such as
nanofiltration or reverse osmosis), heat-treatment (e.g. pasteurization (such as HTST, ESL
or UHT) or sterilization (dry heat or moist heat)) and/or supplementation of additional water
or other ents. Concentration may also be accomplished during the softening of step
(c) or during monovalent ion l, e. g. during nanoflltration, optionally enhanced with
tration. In an optional embodiment, the drying of step (e-i) or (e-ii) occurs prior to
ing of step (d).
Drying step (e-l) 0r (e-il)
The s according to the invention involves a drying step (e-i) or (e-ii) that is performed
on the one or more UF retentates originating from step (a-i) and/or (a-ii) or (a-iii) or step (b)
and at least one of the softened UF permeates originating from step (c), or on the combined
product originating from step (d), preferably the drying of step (e-i) is performed on the
ed product originating from step (d). Drying may occur prior to the combining of
step (d) and/or after the combining of step (d). In case drying occurs after combining, the
combined product originating from step (d) is dried, preferably into a powder. In case drying
occurs prior to combining, the one or more UF retentates originating from step (a) and at
least one of the softened UF permeates originating from step (c) are dried separately, all
preferably into a powder. Alternatively, drying may also occur prior to the combining of
step (d) on one of the one or more UF retentates originating from step (a) and at least one of
the softened UF permeates originating from step (c), preferably into a powder, and the dried
composition, preferably in the form of a powder, is recombined with the remaining liquid
composition. As such, an additional drying step is preferably performed to dry the combined
product originating from step (d) in order to obtain a dry formula.
Drying may be accomplished by any means known in the art, e. g. spray drying, (fluidized)
bed drying, drum drying, freeze drying, roller drying, etc. In an especially preferred
embodiment, drying is accomplished using spray drying, optionally preceded by partial
evaporation of the liquid (e. g. by nanoflltration, reverse osmosis, evaporation).
In an especially preferred embodiment, the drying of step (e-i) occurs after the combining of
step (d), as this order of steps requires the least amount of drying steps to obtain a dry
formula, only one on the combined product originating from step (d). As such, the UP
retentate originating from (a-i) and/or (a-ii) or (a-iii) or step (b), and the liquid softened UF
permeate originating from step (c) is combined with the liquid mixture of UP ates in
step (d), after which the combined product is dried in step (e-i), preferably spray-dried.
Herein, only one drying step is needed in the manufacture of dry formula, preferably an
infant formula base . Normally, more drying steps are , such as drying of a
casein containing composition or drying of skim milk, drying of a whey protein containing
composition and drying of lactose. Drying, such as spray-drying, is a costly procedure,
which is typically performed at high temperatures, such as above 150 0C or even above 180
oC. Reducing the amount of (spray-)drying to a single step greatly improves the efficiency
of the process.
Drying step (e-ii) involves drying of any UF retentate originating from step (a-i) and/or (a-ii)
or (a-iii) or (b) which is not combined in step (d), and drying any of the softened UF
tes originating from step (c) which is not ed in step (d), followed by
ing the dried UF retentate with the dried softened UF permeate to obtain a dry milk
formula. For instance, if the UF retentate originating from (b) is combined in step (d), it is
subsequently dried in step (e-i), and not dried and combined in step (e-ii).
Where the drying of step (e-i) or (e-ii) occurs after the combining of step (d), the combined
t may undergo further processing steps prior to the drying. Such optional further
processing steps include, preferably are limited to, concentrating the liquid stream (zle.
increasing the protein/water weight ratio, e.g. via (partial) ation or ion
techniques such as nanofiltration or e osmosis), heat-treatment (e.g. pasteurization
(such as HTST, ESL or UHT) or sterilization (dry heat or moist heat)) and/or
supplementation of additional water or other components. In an especially preferred
ment, the further processing steps that may be performed on the combined product
prior to the drying of step (e-i) do not include any polyvalent ion removal step or any step
that fractionates the proteins.
The drying of step (e-i) or (e-ii) obtains a dry formula, ably in the form of a powder. In
the context of the present invention, a dry formula has a water content of at most 10 wt%,
preferably 0 — 8 wt%, more preferably 2 — 4 wt%, based on total weight of the composition.
The dry formula may be further processed into nutritional products, preferably products
le for feeding infants.
The process according to the invention yields a dry milk formula, ably in the form of a
powder. In a preferred embodiment, this dry milk product is further processed into a
nutritional product suitable for providing nutrition to a human infant, in particular an infant
between 0 and 36 months of age. Further processing lly comprises on of further
ingredients to the dairy product as known in the art, in ular one or more selected from
vitamins, minerals, lipids, prebiotics, probiotics, lactose. Where appropriate, those
ingredients may also be added to any of the UF retentates or UF tes originating from
step (a), or (b) the softened UF permeate ating from step (c) and the combined product
originating from step (d) prior to drying, or even to any of the incoming first and second
liquid compositions. The skilled person is well aware of the ial and beneficial
ingredients for infant ion, and how they are best blended with the protein fraction.
Further processing of the dry milk formula preferably comprises one or more of
homogenization, heat-treatment, wet and/or dry blending of one of the above mentioned
ingredients.
ective of the combining of the lactose in any of the softened UF permeates originating
from step (c) with any of the UF retentates originating from step (a) or (b), additional
supplementation of lactose may be needed to fulfill the requirements for infant nutrition.
The process according to the invention provides sufficient removal of polyvalent ions and
preferably monovalent ions, by virtue of the ultraflltration of step (a) and the polyvalent ion
removal of step (c), so that all minerals are at or below their required level for infant
nutrition. In case the t of a certain mineral is below the ed level, preferably that
mineral is added to be on target (e.g. EU directive 91/321/EEC, or EU directive
2006/141/EC, US Food and Drug Administration 21 CFR Ch 1 part 107).
The s according to the invention affords residual water at several points, e. g. from the
drying step and optionally as nanoflltration permeate, as reverse osmosis permeate. In a
preferred embodiment, this residual water, optionally after further purification by e.g.
reverse osmosis, is recycled in the process ing to the invention, e. g. used to dilute or
reconstitute the first liquid composition and/or the second liquid composition or as
diaflltration water.
Intermediary products
The process of the t invention generates several intermediary products: 1) the
combined UF retentates originating from step (a-i) and (a-ii), 2) a combined product of the
softened UF permeate and UP retentate of step (d), and 3) a dried combined product of step
(e-i) or (e-ii) in case a dry infant milk formula is meant to be obtained.
Intermediaryproduct I)
Intermediary product 1 is obtained by separately subjecting the UF retentates originating
from (a-i) and (a-ii) to a nanoflltration step and combining the (protein comprising) fraction
thereof (zle. the nanofiltration ate originating therefrom). The UF retentates are
preferably combined in a weight or volume ratio of n 3:1 and 1:3.
Intermediary product 1 is characterized by (based on total dry weight of the composition): a
protein content of between 40 and 52 wt%, wherein casein and whey are present in a weight
ratio which lies between 70:30 and 30:70, lactose in an amount of between 35 and 50 wt%,
and the presence of the following minerals: magnesium in an amount of between 0.01 and
0.30 wt%, calcium in an amount of n 0.80 and 1.70 wt%, orus in an amount of
between 0.60 and 1.50 wt%, sodium in an amount of between 0.10 and 0.60 wt%, chloride
in an amount of n 0.05 and 0.60 wt% and potassium in an amount of between 0.60
and 1.50 wt%. Preferably, this product comprises NPN in an amount of between 1.50 and
3.30 wt%, preferably between 1.90 and 3.0 and fat in an amount of between 2.0 and 3.50,
preferably between 2.30 and 3.30 and ash in an amount of between 4.0 and 10.0 wt%.
Preferably, the intermediary product 1 is .
More preferably, intermediary product 1 is characterized by (based on total dry weight of the
composition): a protein content of between 42 and 50 wt%, wherein casein and whey are
present in a weight ratio which lies between 65:35 and 35:65, lactose in an amount of
between 37 and 46 wt%, and the presence of the following minerals: magnesium in an
amount of between 0.05 and 0.20 wt%, calcium in an amount of between 0.95 and 1.50
wt%, phosphorus in an amount of between 0.60 and 1.30 wt%, sodium in an amount of
between 0.20 and 0.45 wt%, chloride in an amount of n 0.15 and 0.40 wt% and
potassium in an amount ofbetween 0.70 and 1.20 wt%.
Intermediaryproduct 2)
Intermediary product 2 is obtained by separately subjecting the UF retentates originating
from (a-i) and (a-ii) to a concentration step (in this case nanof11tration), combining the
concentrated in comprising) UF retentate (1'.e. the nanof11tration retentate originating
therefrom) and ing the thus obtained liquid composition with the softened and
concentrated UF permeate (1'.e. the UF permeates originating from (a-i) and (a-ii) were
combined after UF, subjected to ion exchange and concentrated by nanof11tration).
Intermediary product 2 is terized by (based on total dry weight of the composition): a
protein content of n 16 and 24 wt%, wherein casein and whey are present in a weight
ratio which lies between 70:30 and 30:70, lactose in an amount of between 65 and 80 wt%,
and the presence of the following minerals: ium in an amount of between 0.01 and
0.25 wt%, calcium in an amount of n 0.20 and 0.80 wt%, phosphorus in an amount of
between 0.40 and 0.80 wt%, sodium in an amount of between 0.20 and 0.80 wt%, de
in an amount of between 0.30 and 0.90 wt% and potassium in an amount of between 0.30
and 0.90 wt%. Preferably, this product comprises NPN in an amount of between 1.30 and
2.80 wt%, preferably between 1.50 and 2.60 and fat in an amount of between 0.5 and 2.0,
preferably between 0.75 and 1.70 and ash in an amount of between 2.0 and 8.0 wt%.
ably, the intermediary product 2 is liquid.
Intermediaryproduct 3)
Intermediary product 3 is a dry milk formula for feeding a human infant with an age of
between 0 - 36 months, such as a -on formula or infant formula, which is obtained by
-)drying intermediary product 2 to which suitable amounts of additional nutrients are
added to reach target levels thereof Said nutrients include dietary fibers (in particular
galacto-oligosaccharide and/or fructo-oligosaccharides), minerals (where ), lactose
(where desired), vitamins, fats. The dry formula contains between 1.0 and 3.0 wt% moisture.
Fi re
The Figure depicts preferred embodiments of the system according to the invention. With
reference to the included Figure, the system according to the invention is bed as
follows.
System
The t invention also relates to an apparatus or system specifically designed to
implement the process according to the invention. The system according to the invention is
preferably a modular system, in which at least three, preferably at least four modules are in
fluid connection with each other, with the option that the fluid connection(s) can be closed
off when and where necessary. Herein, each module may be a separate unit or two or more
modules may be integrated as a single unit. Preferably, each module is a separate unit and is
distinguishable as such in the system.
The system ing to the invention is arranged to receive two incoming liquid
compositions (1'.e. the animal skim milk composition and the animal whey composition as
defined herein) and to discharge one solid composition (e. g. a dry milk formula). In on
thereto, further liquid and/or solid compositions may be received by the system or
discharged from the system.
The system according to the invention comprises an ultrafiltration module (1), comprising
an ultrafiltration membrane (lb). The first module is designed to receive the first liquid
composition (1'.e. the animal skim milk composition as defined herein), or a e of the
first and second liquid itions, via a first inlet (la) to a first side of the UP membrane
(lb). In on, the ultrafiltration module (1) comprises a first outlet (lc) for discharging
WO 63493
an ultrafiltration retentate (UFR) from the first side of the UP membrane (lb) and a second
outlet (ld) for discharging an ultrafiltration permeate (UFP) from the second side of the UP
ne (lb).
The UF membrane has two sides, one for ing the first liquid composition, or a mixture
of the first and second liquid compositions, and discharging the UFR, and one for
discharging the UFP. The retentate is discharged from the same side of the UF membrane
(lb) as the first liquid composition, or a mixture of the first and second liquid compositions,
is ed, and the UF permeate is discharged from the other side of the UF ne. The
UFP thus comprises only material that has permeated through the UF membrane (lb). The
UF membrane (lb) employed in the ltration module (1) can be any UF membrane
known in the art, including ceramic membranes and organic spiral wound membranes,
preferably UF membrane (lb) is an organic spiral wound membrane. UF membrane (lb) has
a molecular weight cut-off that s proteins, such as whey proteins and casein, to remain
in the retentate. Preferably, the molecular weight cut-off is at most 25 kDa, more preferably
at most 10 kDa, and preferably of at least 2.5 kDa, more preferably at least 5 kDa.
Optionally, the system according to the invention comprises a second ultrafiltration module
(10), comprising a second ultrafiltration membrane (10b). The second ultrafiltration module
2O (10) is ed to receive the second liquid composition (i.e. the animal whey composition
as defined herein) via a first inlet (10a) to a first side of the second UF membrane (lOb). In
addition, the second ultrafiltration module (10) comprises a first outlet (lOc) for discharging
a second ultrafiltration retentate (UFR) from the first side of the second UF membrane (10b)
and a second outlet (lOd) for discharging a second ultrafiltration permeate (UFP) from the
second side of the second UF membrane (10b). The second UF ne (lOb) employed
in the ultrafiltration module (10) can be any UF membrane known in the art, including
ceramic membranes and organic spiral wound membranes, preferably UF membrane (10b)
is an organic spiral wound membrane. UF membrane (lOb) has a molecular weight cut-off
that enables proteins, such as whey proteins and , to remain in the retentate.
Preferably, the lar weight cut-off is at most 25 kDa, more preferably at most 10 kDa,
and preferably of at least 2.5 kDa, more preferably at least 5 kDa.
The system according to the invention comprises a polyvalent ion removal module (2) for
removing polyvalent ions from one or more ltration permeates (UFPs) originating
from ultrafiltration module (1) and optionally from ultrafiltration module (10). The
polyvalent ion l module (2) comprises an inlet (2a) for receiving the one or more
UFPs, means for ng polyvalent ions from the UFP (2b), and an outlet (2c) for
discharging a softened UFP. The polyvalent ion removal module (2) removes (significant
amounts of) polyvalent ions (i.e. ions having a positive or negative charge of two or more)
from the UFP, and may also remove (significant amounts of) monovalent ions from the
UFP. Preferably, the polyvalent ion removal module (2) comprises means for ng
(significant amounts of) polyvalent ions and means for removing (significant amounts of)
monovalent ions. In case means for removing (significant amounts of) polyvalent ions and
means for removing (significant amounts of) monovalent ions are both t, those means
may be a single means, capable of ng both polyvalent and monovalent ions, or
preferably two separate means, one capable of removing polyvalent ions (2b) and one
capable of removing monovalent ions (2f). The two te means for removing ions may
be present in two ct units within module (2), wherein an outlet (2d) of the first unit
(2b), preferably for removing polyvalent ions, is in fluid connection with an inlet (2e) of the
second unit (2f), preferably for removing monovalent ions, and outlet (2c) is arranged for
discharging a softened UFP from the second unit (2f).
Any technique known in the art for removing polyvalent and optionally monovalent ions
may be used as means for removing polyvalent ions (2b) and optionally means for removing
monovalent ions (2f). iently, the ion removal unit(s) is/are ed from an
electrodialysis set-up (comprising ion ge membranes and means for applying an
electric potential difference over said ion exchange membranes), an ion exchange set-up
(comprising at least one column filled with anionic and/or cationic resins), a salt
precipitation set-up, a nanofiltration membrane, optionally with an onal inlet for
receiving diafiltration water, or combinations thereof In a preferred embodiment, module
(2) comprises at least one ion exchange column sing anion and/or cation exchange
resins as polyvalent ion removal unit (2b) and a nanofiltration membrane as monovalent ion
removal unit (2f). In an especially preferred embodiment, module (2) comprises at least one
nanofiltration membrane, a salt precipitation set-up and a means for precipitation removal
(preferably an ultrafiltration membrane), more preferably module (2) further comprises an
electrodialysis set-up. Most preferably, module (2) comprises, in the following serially
placed order, at least one nanofiltration membrane, a salt precipitation set-up, a means for
precipitation removal rably an ultraflltration membrane) and an electrodialysis set-up.
In the system according to the invention, the polyvalent ion removal module (2) is arranged
in between the ultraflltration (s) (l and optionally 10) and the mixing module (3).
The system ing to the invention comprises a mixing module (3) for mixing at least
two liquid streams, at least two solid streams (e. g. s) or at least one liquid stream and
at least one solid stream, preferably for mixing at least two liquid streams. The mixing
module (3) preferably enables mixing of the UP retentate originating from ultraf11tration
module (1), the UF retentate originating from ultraflltration module (10) and the softened
UF permeate ating from polyvalent ion removal module (2).
In a first preferred embodiment, the mixing module (3) is designed to mix the UF retentate
originating from ultraf11tration module (1), the UF retentate ating from ultraflltration
module (10) and the softened UF permeate originating from polyvalent ion l module
(2). Thus, in the first preferred embodiment the mixing module (3) is designed to receive a
softened UF permeate ating from polyvalent ion removal module (2) (either as liquid
2O or solid) via a first inlet (3a), the UF retentate ating from ultraflltration module (1)
(either as liquid or solid) via a second inlet (3b) and the UF retentate originating from
ultraflltration module (10) (either as liquid or solid) via a third inlet (3d). The mixing
module (3) further comprises an outlet (3c) for rging a recombined product (either as
liquid or solid).
In a second preferred embodiment, two mixing modules exist, one mixing module (30) for
mixing the first liquid composition with the second liquid composition and for discharging a
mixture of the first and second liquid compositions, and one mixing module (3) for mixing
the mixture of the UF retentate originating from ultraflltration module (1) and the UP
retentate originating from ultraflltration module (lO)with the softened UF permeate
originating from polyvalent ion removal module (2). In the second preferred ment
the first mixing module (30) is designed to receive the first liquid composition via a first
inlet (30a) and the second liquid composition via a second inlet (30b), and to discharge the
mixture of the first and second liquid compositions via an outlet (3 0c). Thus, the first mixing
module (30) comprises a first inlet (30a) and a second inlet (30b) for ing liquid
compositions and an outlet (30c) for discharging a mixed liquid composition. The second
mixing module (3) is designed to receive the softened UF permeate originating from
polyvalent ion removal module (2) (either as liquid or solid) via a first inlet (3a) and the
mixture of the UF retentate originating from ultrafiltration module (1) and the UF retentate
originating from ultrafiltration module (10) r as liquid or solid) via a second inlet (3b),
and to discharge the ined product via an outlet (3 c). Thus, the second mixing module
(3) comprises a first inlet (3a) and a second inlet (3b) for receiving liquid and/or solid
compositions and an outlet (3c) for discharging a recombined liquid or solid composition.
In the mixing module(s) according to the invention, mixing may be accomplished by any
method known in the art. Mixing may be accomplished by merely combining two or more
itions. The mixing module(s) may further comprises mixing means. The mixing
means may be any means suitable for mixing two compositions known in the art, such as “in
pipe” (zle. by the joining of two or more incoming pipes into one single outgoing pipe), in a
(balance) tank or vessel, in an agitated vessel, or by any industrial mixer or blender known
in the art. Suitable mixing means include means for mixing two liquid compositions, e.g.
dynamic mixing or static mixing, or for mixing two solid itions (e. g. two powders),
e. g. a dry blender such as a ribbon blender, a paddle r, a tumble blender and a vertical
r, or one liquid composition and one solid ition, preferably for mixing two
liquid compositions. In an especially preferred embodiment, the mixing means is “in pipe”
or in a balance tank.
Mixing module (3) and optional mixing module (30) may be arranged in the system before
the ultrafiltration module (1) or after the ultrafiltration module (1). In case the mixing
module (3 O) is arranged before the ultrafiltration module (1), the first liquid composition and
the second liquid composition are mixed prior to ultrafiltration. In case the mixing module
(3) is arranged after the ultrafiltration modules (1) and (10), the first and second liquid
compositions are each ultrafiltered separately prior to mixing of the UF ates
originating from ultrafiltration modules (1) and (10).
The system according to the invention ably comprises a drying module (4), which is
arranged for drying at least one liquid composition. The drying module (4) is designed to
e a liquid composition (e.g. the recombined product) via an inlet (4a) to a drying
means (4b), and to discharge a solid composition via an outlet (4c) from the drying means
(4b). The drying means (4b) may be any means suitable for drying a liquid composition
known in the art, e. g. a spray dryer, a (fluidized) bed dryer, a drum dryer, a freeze dryer, a
roller dryer, etc. In an especially preferred embodiment, the drying means (4b) is a spray
dryer.
The drying module (4) may be arranged in the system before the mixing module (3) or after
the mixing module (3), as long as it is arranged after the ultrafiltration module (1) and
optional ultrafiltration module (10). In case the drying module (4) is arranged in between the
ultrafiltration module (1) and optional ultrafiltration module (10) and the mixing module (3),
at least one of the ultrafiltration retentates originating from ultrafiltration modules (1) and
optionally (10) is dried prior to mixing. In case the drying module (4) is arranged after the
mixing module (3), the ultrafiltration retentates are first mixed and then the mixture of the
UF ate originating from ultrafiltration module (1) and the UF retentate originating
from ultrafiltration module (10) is dried.
Optionally, the system ing to the ion comprises r drying module(s), each
for drying at least one liquid stream. Each drying module is designed to e a liquid
composition via an inlet to a drying means, and to discharge a solid composition via an
outlet from the drying means. The drying means may be any means suitable for drying a
liquid composition known in the art, e. g. a spray dryer, a (fluidized) bed dryer, a drum dryer,
a freeze dryer, a roller dryer, etc. In an especially red embodiment, the drying means is
a spray dryer. A further drying module may be arranged in the system before the mixing
module (3) and after the second ultrafiltration module (10), preferably in case the first
drying module (4) is arranged before the mixing module (3) and after the first ultrafiltration
module (1). As such, the ultrafiltration retentates discharged from both ultrafiltration
modules (1) and (10) are dried prior to mixing in the mixing module (3).
In a first preferred embodiment, the system according to the invention comprises two
ultrafiltration modules (1) and (10). Outlet (lc) of the first ultrafiltration module (1) is in
WO 63493
fluid connectivity with inlet (3b) of the mixing module (3), and outlet (ld) is in fluid
connectivity with inlet (2a) of the polyvalent ion removal module (2). Outlet (lOc) of the
second ltration module (10) is in fluid connectivity with inlet (3d) of the mixing
module (3), and outlet (lOd) is in fluid tivity with inlet (2a) of the polyvalent ion
removal module (2). Outlet (2c) is in fluid connectivity with inlet (3 a) of the mixing module
(3), and outlet (3c) is in fluid connectivity with inlet (4a) of the drying module (4). Inlets
(la) and (10a) are arranged to e liquid compositions to the system (e.g. animal skim
milk and animal whey) and outlet (4c) is arranged to discharge a solid composition from the
system (e.g. a dry milk formula). Especially preferred is that module (2) comprises a
polyvalent ion removal unit (2b), preferably at least one ion exchange , and a
monovalent ion removal unit (2f), preferably a nanoflltration ne.
In a second preferred embodiment, the system according to the invention comprises two
mixing modules (3) and (30). Outlet (30c) of the first mixing module (30) is in fluid
connectivity with inlet (la) of the ultraflltration module (1). Outlet (lc) is in fluid
connectivity with inlet (3b) of the second mixing module (3), and outlet (ld) is in fluid
connectivity with inlet (2a) of the polyvalent ion removal module (2). Outlet (2c) is in fluid
connectivity with inlet (3a) of the second mixing module (3), and outlet (3c) is in fluid
connectivity with inlet (4a) of the drying module (4). Inlets (30a) and (30b) are arranged to
2O e liquid compositions to the system (e.g. animal skim milk and animal whey) and
outlet (4c) is arranged to discharge a solid composition from the system (e.g. a dry milk
formula). Especially preferred is that module (2) comprises a polyvalent ion removal unit
(2b), preferably at least one ion exchange column, and a monovalent ion removal unit (2f),
preferably a nanoflltration membrane.
The system according to the invention may comprise further s or further features as
described here below.
In a further preferred embodiment, the system according to the invention comprises one or
more concentration module(s) for concentrating (a) liquid stream(s). Such a concentration
module comprises an inlet for receiving a liquid ition to a means for concentrating, a
means for concentrating and an outlet for discharging a concentrated liquid composition.
Any concentration technique known in the art may be used as means for concentrating.
WO 63493
Conveniently, the means for concentrating is selected from an evaporation set-up (e.g. by
increasing the temperature and/or ng the pressure) or a membrane filtration set-up
(e.g. a reverse osmosis membrane or a nanofiltration membrane). A concentration module
may also be combined with the polyvalent ion removal module (2), as such accomplishing
concentration during monovalent ion removal (e. g. using nanofiltration optionally enhanced
with diafiltration).
In a further preferred embodiment, the system according to the invention comprises means
for recycling ual) water from outgoing streams to incoming streams. al water
may be obtained in the drying module (4), in the polyvalent ion removal module (2) (e. g. as
nanofiltration permeate) and in each of the concentration modules (e. g. as reverse osmosis
permeate). Preferably, at least one of the drying module (4), the polyvalent ion l
module (2) and a concentration module further comprises an additional outlet for
discharging water from the module, more preferably at least one of the tration
modules comprises such an additional outlet. Most preferably, the drying module (4), the
polyvalent ion removal module (2) and each of the tration modules each comprise
such an outlet. The residual water may be used to dilute any of the incoming liquid
compositions, e. g. the first liquid ition and/or the second liquid composition, or may
be used as diafiltration water, e. g. in the polyvalent ion removal module (2). Preferably, the
2O first ltration module (1) and/or the second ultrafiltration module (10) module and/or
the polyvalent ion removal module (2) further comprise an additional inlet for receiving
residual water. The skilled person appreciates that the outlets for discharging residual water
are in fluid connectivity with the inlets for receiving residual water, preferably by means of
a conduit, wherein optionally one or more collection tanks or one or more further
purification means (e.g. reverse osmosis membranes) are integrated.
In a further preferred embodiment, the system according to the ion comprises means
for heat-treating a liquid composition. Any of the liquid compositions which are led through
the system according to the invention may suitably be heat-treated, using any heat-treatment
technique known in the art. iently, the system according to the invention comprises
at least one heat-treating , arranged for heat-treating a liquid composition. Such a
heat-treatment module comprises an inlet for ing a liquid composition to a means for
heat-treatment, a means for heat-treatment and an outlet for discharging a heat-treated liquid
ition. Any heat-treatment technique known in the art may be used as means for heat-
treatment, such as pasteurization or sterilization set-up. Preferably, a plate xchanger
(PHE) and/or a direct steam injection/infusion (D81) is used as heat-treatment means.
The system ing to the invention may further comprise chilling means, preferably to
enable the system to operate at a temperature below 15 0C, more ably below 12 oC.
The skilled person will understand that freezing of the liquid stream is highly undesirable, at
that the temperature should be kept high enough for the different liquid streams to remain
. Typically, the chilling means enable the system to operate at a temperature of at least
2 oC. Each module may have a separate chilling means, or a central chilling means may be
installed to regulate the temperature in the entire system. Preferably, the chilling means are
selected from cooling tower, heat-exchanger (plate or tubular, preferably in connection with
the PHE used for reatment), cooling by coolant (heat-transfer fluid), pumpable ice
technique.
In case a module comprise a nanofiltration membrane, the nanofiltration may optionally be
enhanced by diaflltration. To accomplish diaflltration, the module requires an additional
inlet for receiving water to the first side of the nanofiltration membrane, as such enabling
dilution and re-flltration of the nanofiltration retentate. In a preferred embodiment, the
2O polyvalent ion removal module (2) comprises such an additional inlet (2d).
All filtration modules preferably comprise means to tate the permeations of the solvent
and optionally small solutes through the membrane. Any means known in the art may be
used to accomplish easy permeation, such as using gravity or the application of
transmembrane re (TMP). TMP may be lished by pressurizing the first side of
the membrane (i.e. the retentate side) or by depressurizing the second side of the membrane
(i.e. the permeate side). Suitably, a pump using hydrostatic pressure to pressurize the first
side of the membrane and/or a pump generating suction at the second side of the membrane
is used. Suitable pumps include centrifugal pumps and positive displacement pumps,
preferably fugal pumps are used.
In the system according to the invention, the ent modules are interconnected, 1'.e. the
outlet of one module is in fluid connectivity with the inlet of another , preferably by
WO 63493
means of a conduit. The different modules of the system, especially the ultraflltration
module (1), the mixing module (3) and the drying module (4), may be interconnected in
different configurations, as long as the system is arranged to implement the process
according to the invention.
The system according to the invention preferably operates with 500 — 2500 kg, more
preferably 800 — 1800 kg, most preferably 1000 — 1400 kg dry matter of the first liquid
composition, preferably of animal skim milk, incoming per hour. The system according to
the invention preferably es with 1500 — 5000 kg, more preferably 2200 — 4000 kg,
most preferably 2600 — 3000 kg dry matter of the second liquid composition, preferably of
animal whey, incoming per hour. The system according to the invention preferably es
with 750 — 4000 kg, more preferably 1000 — 3000 kg, most ably 1500 — 2000 kg UF
retentate discharged from the ultraflltration module(s) per hour from both incoming streams
combined. The process according to the invention preferably operates with 1000 — 5000 kg,
more preferably 1500 — 4000 kg, most preferably 2000 — 2500 kg UF permeate discharged
from the ultraflltration module(s) per hour from both incoming streams ed.
The invention will now be illustrated by several es which are not meant to limit the
invention in any manner.
Example I
400 kg of pasteurized cows’ skim milk with a casein to whey protein weight ratio of 80:20
was subjected to ultraflltration over a Synder ST3 838 UF ne having a MWCO of 10
kDa. Ultraflltration was performed at a temperature between 8 and 10 0C, with a
transmembrane pressure of 2 bar and a VCF of about 2. The permeate was ted in a
flow rate of up to 260 L/h. 208 kg of a UF permeate (UFPl) and 211 kg of a UF retentate
(UFRl) was obtained. The compositions of the incoming skim milk and the products of the
ultraflltration are given in table 1. The slight increase in total weight of the final products
(UFRl and UFPl) compared to the incoming skim milk can be attributed to dilution of the
plant dead volume during the changeover from product to water during plant flushing. As
can be seen from the data of table 1, the UF retentate is enriched in proteins, s the UF
permeate is ed in lactose.
Table I .' itions ofexample I (in wi% based on total dry weight)
Component Cows’ skim milk UFRl UFPl
protein 36.2 51.7 0.0
Lactose 51.8 36.5 87.6
ash 8.7 8.4 9.1
- Na 0.46 0.35 0.70
- K 1.83 1.40 2.69
- Cl 1.13 0.66 1.61
- P 1.16 1.32 0.76
- Ca 1.37 1.67 0.80
- Mg 0.12 0.12 0.13
Example 2
1000 kg of pasteurized sweet whey with whey proteins as the sole protein source was
subjected to ultrafiltration over a Synder ST3838 UF membrane having a MWCO of 10
kDa. Ultrafiltration was performed at a temperature between 10 and 12 0C, and with a
transmembrane pressure of 2 bar and a VCF of about 5. The permeate was ted in a
flow rate of up to 400 L/h. 818 kg of a UF permeate (UFP2) and 195 kg of a UF retentate
(UFR2) was obtained. The compositions of the incoming sweet whey and the products of the
ultrafiltration are given in table 2. The slight increase in total weight of the final products
(UFRl and UFPl) compared to the incoming sweet whey can be attributed to dilution of the
plant dead volume during the changeover from product to water during plant flushing.
Table 2.‘ Compositions ple 2 (in wi% based on total dry )
Component Sweet whey UFR2 UFP2
Protein 9.7 35.1 0.0
lactose 76.9 50.0 87.4
ash 8.6 6.7 9.3
- Na 0.67 0.49 0.74
- K 2.58 1.92 2.84
- Cl 1.44 0.95 1.69
- P 0.82 0.58 0.73
- Ca 0.81 0.69 0.86
-Mg 0.14 0.10 0.15
Example 3
The UFPl of example 1 and the UFP2 of example 2 were combined in a weight ratio of
/80 to obtain 799 kg of a combined UFP. The combined UFP was subjected to ion
exchange to produce a softened UFP, and subsequently to nanof11tration ed with
diaf11tration. Ion exchange employed an anionic resin charged with chloride ions and a
cationic resin charged with sodium ions, to exchange the polyvalent ions for sodium and
chloride. Ion exchange operated at a pH between 2.4 and 4.3 and a temperature between 5
and 10 oC. Nanoflltration employed a Synder NFX 3838 NF membrane having MWCO of
150 — 300 Da, operated at a temperature between 8 and 22 0C, and with a transmembrane
pressure of 2 bar. The permeate was collected in a flow rate of up to 400 L/h. Two
diaflltration volumes of, 200 L of water were added sequentially when the retentate total
solids content reached 20%. The softened UFP was concentrated to a final total solid t
of about 20 %. 178 kg of a softened UFP concentrate was obtained as a 1tration
retentate , er with 1225 kg of a nanof11tration permeate (NFPl). The
compositions of the incoming combined UFP and the products of the nanof11tration are
given in table 3. The great majority of the polyvalent ions were removed during ion
exchange and the great majority of the monovalent ions ended up in the NFPl. The softened
UFP concentrate (NFRl) ned almost exclusively lactose.
2014/050202
Table 3 .' itions ofexample 3 (in wi% based on total dry weight)
component Combined UFP NFRl softened UFP concentrate
(NFP1)
protein 0.0 0.0 0.0
lactose 86.8 97.2 11.2
ash 9.2 2.4 74.7
-Na 0.71 0.61 24.7
- K 2.66 0.32 9.8
- Cl 1.70 0.84 44.9
- P 0.75 0.23 0.34
- Ca 0.84 0.06 0.36
- Mg 014 0.00 0.00
Example 4
The UFR1 of example 1 was concentrated and subjected to monovalent ion removal by
nanofiltration over a Synder NFX 3838 NF ne having MWCO of 150 — 300 Da.
Nanofiltration operated at a temperature between 8 and 20 0C, and with a transmembrane
pressure of 2 bar and VCF of about 2. The permeate was collected in a flow rate of up to 220
L/h. 108 kg of an UFR1 concentrate as tration retentate (NFR2) was obtained,
together with 149 kg of a nanofiltration permeate (NFP2). Using nanofiltration, the UFR1 is
concentrated to a total solid content of about 18 %. The composition of the NFR2 product of
the nanofiltration is given in table 4.
Table 4: Composition ofexample 4 (in wt% based on total dry weight)
component NFR2
protein 55.6
lactose 33.4
ash 7.8
- Na 0.26
- K 1.06
- Cl 0.27
- P 1.33
- Ca 1.70
- Mg 0.12
Example 5
The UFR2 of e 2 was concentrated and subjected to monovalent ion removal by
nanofiltration over a Synder NFX 3838 NF membrane having MWCO of 150 — 300 Da.
Nanofiltration operated at a temperature between 8 and 20 0C, and with a transmembrane
pressure of 2 bar. The te was collected in a flow rate of up to 400 L/h. 73 kg of an
UFR2 concentrate as nanofiltration retentate (NFR3) was obtained, together with 148 kg of
a nanofiltration permeate (NFP3). Using tration, the UFR2 is trated to a total
solid content of about 18 %. The composition of the NFR3 product of the nanofiltration is
given in table 5.
Table 5 .' Composition ofexample 5 (in wt% based on total dry weight)
component NFR3
protein 35.8
lactose 51.0
ash 5.6
- Na 0.35
- K 0.82
- Cl 0.26
_ P 0.64
- Ca 0.66
- Mg 0.11
Example 6
The aim is to produce a mixture with a caseinzwhey ratio of 40:60. To this end, the UFRl
concentrate of example 4 (NFR2) is mixed with the UFR2 concentrate of e 5 (NFR3)
in a weight ratio of 59 kg:87.62 kg (based on a liquid composition) or in a weight ratio of
.59 kg: 16.45 kg (based on a dry composition) tively, to produce a mixture of UFRl
and UFR2. Besides the in table 6 mentioned constituents, the NFR2/NFR3 e
comprises NPN at 2.82 wt% and fat at 3.08 wt%.
Table 6: Composition ofexample 6 (in wt% based on total dry weight)
component NFR2/NFR3 mixture
protein 43.6
lactose 44.1
ash 6.5
- Na 0.32
- K 0.91
- Cl 0.27
- P 0.91
- Ca 1.07
- Mg 0.12
Combining the UFRl concentrate of example 4 (NFR2) with the UFR2 concentrate of
example 5 (NFR3) in another selected weight ratio allows to obtain a mixture which
comprises casein to whey proteins in a desired ratio that falls within the claimed range.
Addition of a softened and optionally trated UF permeate (which is substantially free
from proteins) allows one to increase the amount of e to a desired level. The obtained
mixture can be spray-dried into a dry milk formula. For ce, addition of suitable
s of required nutrients and minerals, where needed, allows one to obtain a growing-
up formula with a 40:60 casein to whey protein ratio. Alternative mixtures of UFRl and
UFR2 where made to produce other mixtures of UFRl and UFR2 that comprised a 50:50
and 60:40 casein to whey ratio.
Example 7
A ed UFP concentrate was recombined with the mixture of UFRl and UFR2 to
produce a ition with a 60:40 casein to whey n ratio. The softened UFP
concentrate was combined with the mixture of UFRl and UFR2. The UFRl concentrate of
example 4 (NFRZ), the UFR2 concentrate of example 5 (NFR3) and the ed UFP
concentrate (NFRl) of example 3 are mixed in a weight ratio of 88.51 81 kg:188.77
kg (based on a liquid composition) or in a weight ratio of 15.88 kg:8.23 kg:38.57 kg (based
on a dry composition) respectively, to produce a mixture of UFRl, UFR2 and softened UFP.
Besides the in table 7 mentioned constituents, the NFRl/NFRZ/NFR3 mixture comprises
NPN at 1.67 wt% and fat at 1.01 wt%.
Table 7.‘ Composition ofexample 7 (in wt% based on total dry weight)
Component NFRl/NFRZ/NFR3 mixture
Protein 18.8
Lactose 74.9
Ash 4.2
- Na 0.49
- K 0.58
- Cl 0.62
- P 0.56
- Ca 0.55
- Mg 0.05
Combining the softened UFP concentrate with the mixture of UFRl and UFR2 in other
selected weight ratios allows obtaining a mixture which comprises casein to whey proteins
in a desired ratio that falls within the claimed range. The addition of the softened and
optionally concentrated UF permeate (which is substantially free from proteins) allows to
increase the amount of lactose to a higher levels as shown. The obtained mixture can be
spray-dried into a dry milk formula. For instance, addition of suitable amounts of required
nts and minerals, where needed, allows one to obtain a growing-up formula with a
60:40 casein to whey protein ratio. ative mixtures where made in a r fashion to
obtain compositions that comprised a 50:50 and 40:60 casein to whey ratio.
Example 8
onation of reconstituted skim milk powder (SMP) and reconstituted sweet whey
powder (SWP) according to the invention was performed using a combination of unit
operations, to prepare three types of infant nutrition base products. tituted SMP and
reconstituted SWP were each subjected to UF (step 1), the retentates (UFRs) were subjected
to NF (step 2) and the permeates (UFPs) to poly- and monovalent ion removal (step 3).
Subsequently, the NF retentates (NFRs) from step 2 and the softened UFPs from step 3 are
combined in step 4. The compositions of SMP and SWP are given in table 8. Each step of
the process operated in steady state conditions for 4 — 10 h, during which an acceptable
average flux was achieved throughout the entire production sequence. Concentration factors
for the membrane filtration steps are given in “mass concentration factor” (MCF), which are
calculated in the same way as a VCF, but using weight d of volume. It can be assumed
that MCF = VCF, since all densities are close to that of water (1000 kg/m3) and all solids
present in the ng stream end up in the retentate and permeate streams. Over time,
slight variations were observed for the MCFs. Here below, the MCF range is given or the
deviation from the given value was less than 10 % at all times.
Table 8: Compositions ofSMP and SWP (per 100 gpowder)
Component SMP SWP
Protein (g) 35.2 13.5
Lactose (g) 53.3 76.6
ash (g) 7.83 8.38
- Na (mg) 397 666
- K (mg) 1690 3040
- Cl (mg) 979 1500
- P (mg) 1130 722
- Ca (mg) 1260 614
- Mg (mg) 106 130
-Zn (mg) 4.8 0.17
Step 1: Fractionation of tituted SMP and tituted SWP was performed using two
3838 10 kDa ultraf11tration membranes in series (Synder Filtration), to separate the feed
materials into a n enriched retentate and a lactose/milk salts enriched permeate at 10
°C . The tituted skim milk feed material (~2800 kg) at a total solids t of 8.64 %
w/w solid, pH of 6.9 at 5.8 °C, was fractionated using a mass concentration factor of 2,
while the reconstituted sweet whey feed material (~3 500 kg) at a total solids content of 6.1
% w/w solid, pH of 6.63 at 6.8 °C was fractionated using a mass concentration factor of 5.5
The utritional and mineral distribution of the liquid retentate and permeate streams
from UF1 and UF2 are presented in table 9. The permeates were collected with an average
flux of 10.54 kg/mZ/h (for SM) and 20.21 kg/mZ/h (for SW).
Table 9: itions of UFRS and UFPS (per 100 g)
Component UFRl (SM) UFPl (SM) UFR2 (SW) UFP2 (SW)
Total solids (g) 11.57 5.29 9.00 5.32
Protein (g) 6.36 0.14 3.47 0.16
Lactose (g) 4.14 4.68 4.57 4.71
ash (g) 0.97 0.48 0.66 0.44
- Na (mg) 38.5 34.0 38.2 32.6
-K(mg) 162.4 142.3 117.9 99.8
— Cl (mg) 79.1 91.7 91.7 107.9
— P (mg) 142.3 37.5 77.9 30.4
— Ca (mg) 190.5 32.8 79.1 19.2
— Mg (mg) 13.7 6.0 10.0 6.1
— Mn (mg) 0.004 0.00 0.001 0.00
— Fe (mg) 0.042 0.10 0.051 0.072
- Cu (mg) 0.014 0.07 0.033 0.010
-Zn (mg) 0.80 0.16 0.032 0.010
M: Post ultrafiltration of the reconstituted skim milk and sweet whey powder streams,
the subsequent retentates UFRl and UFR2 were concentrated and partially demineralised
using a 3838 150-300 Da nanofiltration (NF) membrane (GEA Filtration, Denmark). For
concentration and demineralisation of ~ 500 kg of UFRl (pH 6.82 at 6 °C) to 26 % w/w
solids content, NF1 used two NF membranes in series, while for concentration and
demineralisation of ~ 640 kg UFR2 (pH 5.88 at 6.5 °C) to 28 % w/w solids content a single
NF membrane was used in NF2. NF1 operated within a mass concentration factor range of
1.8 — 2.2 while NF2 operated within a mass concentration factor range of 2.6 — 3. Both NF1
and NF2 were operated within the temperature range of 13-14 °C. The permeates were
collected with an average flux of 1.64 kg/mZ/h (for UFRl) and 9.64 kg/mZ/h (for UFR2).
The macronutritional and mineral distribution of the liquid retentate and te s
from NFl and NF2 are presented in table 10. The process yielded for NFRl and NFR2 milk
protein concentrate (MPC50) and whey protein concentrate (WPC3 5) powders respectively.
Table 10: Compositions ofNFRS andNFPS (per 100 g)
Component NFRl (SM) NFPl (SM) NFR2 (SW) NFP2 (SW)
Total solids (g) 24.30 0.36 24.63 0.35
Protein (g) 12.8 0.08 9.45 0.08
Lactose (g) 9.67 0.05 13.65 0.05
ash (g) 1.66 0.23 1.29 0.28
- Na (mg) 51.2 23.6 51.7 52.7
- K (mg) 222.8 92.3 168.7 156.6
— Cl (mg) 55.3 92.9 109.4 87.4
- P (mg) 273.1 13.0 203.8 103.6
— Ca (mg) 381.2 2.02 210.6 79.0
— Mg (mg) 27.7 0.23 26.6 24.1
— Mn (mg) 0.008 0.00 0.002 0.00
— Fe (mg) 0.061 0.00 0.12 0.019
- Cu (mg) 0.021 0.007 0.068 0.009
— Zn (mg) 1.61 0.013 0.067 0.011
Sig: Milk and whey permeates from UFl and UF2 respectively were trated and
partially demineralised separately by NF3 using two 3838 150-300 Da nanofiltration (NF)
membranes in series (GEA Filtration, Denmark). For concentration and demineralisation
~1000 kg of UFPl (pH 5.9 at 6.9 °C) was concentrated to 22 % w/w solids content. For
concentration and ralisation ~1000 kg of UFP2 (pH 5.6 at 6 °C) was concentrated to
22 % w/w solids content. For concentration of both UFPl and UFP2, NF3 operated within a
mass tration factor range of 3.5 — 4 at a temperature of 10 °C. Average permeate
fluxes amounted to 9.73 h (for UFPl) and 10.9 kg/mZ/h (for UFP2). The
macronutritional and mineral distribution of the liquid retentate and permeate streams from
NF3 are presented in table 11.
Post concentration and demineralisation of UFPl and UFP2 by NF3, both retentates were
uently indirectly heated to 82 °C using an indirect plate heat exchanger feeding a 250
L jacketed stainless steel . Once the retentate from NF3 was in the storage vessel the
pH was adjusted to 7.2 (at 82 °C) using a 30 % w/w NaOH solution, causing the
precipitation of calcium salts primarily of phosphate and citrate. The itated solution
was held at 82 °C for 20 minutes to maximise the itation reaction followed by cooling
to 20 °C using an indirect plate heat exchanger g a second 250 L jacketed stainless
steel vessel. The precipitated material was removed from the NF3 retentate stream (post
precipitation) by UF3 using two 3838 10 kDa ultraflltration membranes in series (Synder
Filtration). UF3 operated within a mass concentration factor of 10 at a temperature of 20 °C.
The macronutritional and mineral distribution of the liquid ate streams from UF3 are
presented in table 12. The s according to the invention yielded ~50 %
demineralisation in the UF3 retentates compared to UFPl and UFP2 on a dry matter basis.
The liquid retentate streams from UF3 were ed in a stainless steel vessel at 40 °C.
The compounded batch (65 kg total mass) constituted the UFR3 from skim milk and the
UFR3 from sweet whey in a mass ratio of 20:80 respectively. The batch was subsequently
demineralised using a pilot electrodialysis plant (Pl EDR—Y, MemBrain). The endpoint of
the demineralisation was determined based on the relationship between conductivity of the
demineralised lactose and the ash content therein (endpoint: conductivity < 1 ms; ash
content < 0.75 wt% based on dry matter). Once the endpoint of the demineralisation was
reached, the demineralised lactose concentrate stream was cooled to 5 °C followed by
determination of total solids t of the ED product as 16.62 % w/w.
Table I]: Compositions ofNFR3s andNFP3s (per 100 g)
Component NFR3 (SM) NFP3 (SM) NFR3 (SW) NFP3 (SW)
Total solids (g) 20.67 0.32 23.55 0.42
Protein (g) 0.33 0.09 0.37 0.09
e (g) 19.28 0.00 18.59 0.00
ash (g) 1.07 0.24 1.08 0.30
-Na (mg) 58.6 24.0 65.59 33.41
-K(mg) 253.8 94.9 255.94 118.96
- Cl (mg) 68.0 106.9 80.05 132.15
-P(mg) 133.4 5.68 115.36 10.61
- Ca (mg) 125.4 1.80 100.31 1.06
- Mg (mg) 22.9 0.16 27.69 0.16
- Mn (mg) 0.0002 0.0002 0.0002 0.000
- Fe (mg) 0.00 0.0005 0.0231 0.0212
- Cu (mg) 0.006 0.007 0.0075 0.0078
- Zn (mg) 0.023 0.012 0.0402 0.016
Table 12: Compositions of UFR3s and UFP3s (per 100 g)
Component UFP3 (SM) UFP3 (SW) ED product
Total solids (g) 17.95 19.26 16.62
Protein (g) 0.30 0.35 0.33
Lactose (g) 16.78 17.98 16.17
ash (g) 0.87 0.93 0.12
- Na (mg) 159.9 142.2 18.4
- K (mg) 226.7 230.3 3.0
- Cl (mg) 64.9 79.5 2.4
-P(mg) 66.5 71.5 19.5
- Ca (mg) 15.0 36.9 7.9
- Mg (mg) 16.3 19.8 0.0
- Mn (mg) 0.00 0.00 0.00
- Fe (mg) 0.00 0.0204 0.00
- Cu (mg) 0.016 0.0078 0.00
- Zn (mg) 0.020 0.0168 0.00
Sip—4: The final phase in the process was the tion of nutritionally balanced
infant/toddler nutrition using the materials prepared in the preceding steps (1 — 3). As such
the lactose concentrate solution produced in step 3 (ED product) was used as the liquid
stream to which the NFRl and NFR2 were added, giving the desired (legally required)
content and ratio of protein (casein/whey) and lactose for tage infant milk (IF), follow
on milk (F0) and growing up milk (GUTVI). The streams were blended in the ratios
mentioned in table 13. At this stage the liquid concentrate stream comprising demineralised
lactose (from ED product), MPC (from NFRl) and WPC (from NFR2) was pre-heated to 50
°C followed by dosing of oil and GOS to meet the nutritional requirements. The liquid
concentrate infant formula streams were then heated treated at 85 °C for 5 min in an ct
tubular heat exchanger (Mircothermics), homogenised downstream from the heat treatment
at first and second stage pressures of 125 and 25 bar tively (at 60 °C), followed by
evaporation to 55 % w/w solids content in a single effect falling film evaporator, operating
at 55 °C, and spray drying using a single stage spray dryer equipped with 2 fluid nozzle
atomisation operating at an inlet and outlet temperature of 175 °C and 90 °C tively.
The ional composition of the IF, F0 and GUTVI powders ed is outlined in table
Note that all components mentioned in table 14, except for the fat and part of the
carbohydrates (GOS) originate from the skim milk and sweet whey starting materials. All
2O components in table 14 are either within the acceptable ranges for that component, or are
below those acceptable ranges. For those components who’s content is below acceptable,
fortification would be required to se their content to within acceptable . It is
important to note that none of the mentioned components, not even the polyvalent ions, are
present above their acceptable range, which would be unacceptable as taking out is
impossible, while adding one or a few components may happen straightforward. The
possibility of preparing different infant nutritional products, all according to legal standards,
demonstrates the versatility and lity of the process according to the invention.
Table 13: Blending ratios, expressed in kg ofliquid concentrate per 100 kg ofdry powder
Streams IF FO GUTVI
I\FR1 (kg) 43.49 55.74 56.33
I\FR2 (kg) 61.72 47.47 47.97
ED product (kg) 191.83 215.90 208.86
Table 14: Compositions ofIF, FO and GUMpowders (per 100 g)
Component IF FO GU1V1
Moisture (g) 1.26 1.68 2.38
Protein (g) 11.5 11.69 11.56
ydrate (g) 56.62 59.23 63
Fat (g) 28.71 25.49 21.3
Ash (g) 1.91 1.91 1.76
- Na (mg) 192 156 171
- K (mg) 290 278 240
- C1 (mg) 88.5 83.5 109.5
- P (mg) 310 300 285
- 804 (mg) 36 33 38
- 1 (mg) 37 36 37
- Se (Hg) 7.7 8.4 6.7
-Ca(mg) 354 351 318
_ Mg (mg) 41 39 34
-211 (mg) 1 1.1 1.06
Carnite (mg) 21.3 23.6 23.8
Choline (mg) 216 231 235
Inositol (mg) 39.9 47.4 50.4
Biotin (Hg) 10.7 11.4 11
Folic acid (Hg) 41.4 38.8 32.1
Pantothenic acid (mg) 2-31 288 2-84
Vitamin B1 (mg) 0.17 0.17 0.17
Vitamin 312 (Mg) 1.38 1.39 1.29
Bitamin B2 (mg) 1.23 1.2 1.27
Vitamin B6 (mg) 0.1205 0.1140 0.1288
Claims (18)
1. A process for obtaining a dry milk formula, comprising the following steps: (a-i) ultrafiltration (UF) of an animal skim milk composition comprising 70 – 90 wt% casein and 10 – 30 wt% whey proteins, based on total protein, and (a-ii) ultrafiltration of an animal whey ition comprising 0 – 25 wt% casein and 75 – 100 wt% whey proteins, based on total protein; or (a-iii) iltration of a e of the itions of (a-i) and (a-ii), (b) preferably combining of the UF retentate originating from step (a-i) with the UF ate originating from step (a-ii); (c) removing polyvalent ions from the UF permeate originating from step (a-i) and/or (a-ii) or (a-iii) to obtain at least one softened UF permeate; (d) combining the at least one softened UF permeate originating from step (c) with a UF retentate originating from step (a-i) and/or (a-ii), or (a-iii) or (b) to obtain a combined product; and (e-i) drying the combined product originating from step (d) to obtain a dry milk formula, and/or (e-ii) drying any UF retentate originating from step (a-i) and/or (a-ii) or (a-iii) or (b) which is not combined in step (d), and drying any of the softened UF permeates originating from step (c) which is not combined in step (d), ed by combining the dried UF retentate with the dried softened UF permeate to obtain a dry milk formula.
2. The process according to claim 1, wherein the animal skim milk comprises 75 – 85 wt% casein and 15 – 25 wt% whey proteins, based on total protein, preferably about 80 wt% casein and 20 wt% whey protein, preferably the animal skim milk composition of step (a-i) comprises or is animal skim milk.
3. The s according to claim 1, wherein the animal whey composition comprises 0 – 20 wt% casein and 80 – 100 wt% whey proteins, based on total protein, preferably 0 – 10 wt% casein and 90 – 100 wt% whey proteins, more preferably 0 – 5 wt% casein and 95 – 100 wt% whey proteins, preferably the animal whey composition of step (a-ii) comprises or is animal whey.
4. The process according to any one of claims 1 – 3, wherein a UF permeate originating from step (a-i) and a UF permeate originating from step (a-ii) are combined prior to said removal of polyvalent ions of step (c).
5. The process according to any one of claims 1 – 4, wherein a UF retentate originating from step (a-i) and/or (a-ii) is/are concentrated prior to the combining of step (b), (d) or drying of step (e-i) and/or (e-ii); and/or a UF retentate originating from step (a-iii) and/or (b) is/are concentrated prior to the combining of step (d) or drying of step (e-i) and/or (e-ii).
6. The process according to any one of claims 1-5, wherein the UF permeate originating from step (a-i) is combined with a permeate originating from (a-ii) prior to polyvalent ion l of step (c), and preferably trated after polyvalent ion removal of step (c).
7. The process according to any one of claims 1-6, wherein the softened UF permeate ating from step (c) and/or the combined product of step (d) is/are concentrated, prior to the combining of step (d) or the drying of step (e-i) and/or (e-ii).
8. The process ing to any one of claims 5-7, wherein concentration occurs by reverse osmosis and/or nanofiltration.
9. The process according to any one of claims 1 – 8, wherein polyvalent ion removal of step (c) occurs by electrodialysis, ion exchange, e crystallization and/or salt precipitation.
10. The process according to any one of claims 1 – 9, wherein the softened UF permeate of step (c) and/or the UF ate originating from step (a-i) and/or (a-ii) or ) or (b) is/are subjected to monovalent ion removal, preferably by odialysis, nanofiltration, lactose crystallization and/or salt precipitation.
11. The process according to any one of claims 1 – 10, wherein a UF retentate originating from step (a-i) and/or (a-ii), or (a-iii) or (b) and/or a UF permeate originating from step (a-i) and/or (a-ii) or (a-iii), and/or the softened UF permeate originating from step (c) or the combined product of step (d) is/are reated, by direct steam injection (DSI), prior to the drying of step (e-i) and/or (e-ii); preferably the combined product of step (d) is heattreated , preferably by DSI, prior to the drying of step (e-i); or preferably any of the UF retentates of step (e-ii) and/or any of the softened UF permeates of step (e-ii) is heat-treated, preferably by DSI, prior to the drying of step (e-ii).
12. The process according to any one of claims 1 – 11, wherein drying of step (e-i) and/or (eii ) is by spray-drying.
13. The process according to any one of claims 1 – 12, wherein the combined product originating from step (d), the dried combined product of (e-i), and/or the dried UF retentate of (e-ii) which is combined with the dried softened UF permeate of (e-ii) in step (e-ii) is further processed into a nutritional product for providing nutrition to infants.
14. The process according to any one of claims 1 – 13, wherein the animal skim milk composition and animal whey composition of step (a-iii) or the UF retentates originating from step (a-i) and (a-ii) are combined in such a ratio that a product is obtained having a casein:whey n weight ratio of between 75:25 to 30:70, preferably n 64:36 to 36:64, more preferably 60:40 to 40:60 or about 50:50.
15. The process ing to any one of claims 1 – 13, wherein the mixture of the animal skim milk composition and animal whey composition of step ) or the combined UF ate of step (b), or the combined product of step (d), the dry milk formula of (e-i) or the dry milk formula of (e-ii) has a casein:whey protein weight ratio of between 75:25 to 30:70, preferably between 64:36 to 36:64, more preferably 60:40 to 40:60 or about 50:50
16. A modular system, comprising: (1) an ultrafiltration module, sing (1a) an inlet for receiving a first liquid ition and/or a second liquid composition, or a mixture thereof, to a first side of an ultrafiltration membrane, (1b) the ultrafiltration membrane, (1c) a first outlet for discharging an ultrafiltration retentate (UFR) from the first side of the ultrafiltration membrane, and (1d) a second outlet for discharging an ultrafiltration permeate (UFP) from the second side of the ultrafiltration ne; (2) a polyvalent ion removal module, comprising (2a) an inlet for receiving the UFP originating from the ultrafiltration module (1), (2b) means for removing polyvalent ions, and (2c) an outlet for discharging a softened UFP; (3) at least one mixing module, comprising (3a) a first inlet for ing the softened UFP originating from the polyvalent ion removal module (2), (3b1) a second inlet for receiving the first liquid composition or an UFR of the first liquid composition and a third inlet for receiving the second liquid composition or an UFR of the second liquid, or (3b2) a second inlet for receiving the mixture of the first liquid composition and the second liquid composition or an UFR of the first liquid composition and an UFR of the second liquid composition, and (3c) an outlet for discharging a recombined product; and (4) a drying module, comprising (4a1) a first inlet for receiving the UFR originating from the ultrafiltration module (1) and a second inlet for receiving the softened UFP originating from the polyvalent ion removal module (2), or (4a2) an inlet for receiving the recombined t originating from the mixing module (3), (4b) drying means, and (4c) an outlet for rging a dried ition.
17. A process ing to claim 1, substantially as herein described or exemplified with reference to the accompanying drawings.
18. A system according to claim 16, substantially as herein described or exemplified with reference to the anying drawings. WO 63493
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NLPCT/NL2013/050248 | 2013-04-03 | ||
PCT/NL2013/050248 WO2014163485A1 (en) | 2013-04-03 | 2013-04-03 | Process and system for preparing dry milk formulae |
PCT/NL2014/050202 WO2014163493A1 (en) | 2013-04-03 | 2014-04-03 | Process and system for preparing dry milk formulae |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ712773A NZ712773A (en) | 2021-02-26 |
NZ712773B2 true NZ712773B2 (en) | 2021-05-27 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2014250177B2 (en) | Process and system for preparing dry milk formulae | |
US10021890B2 (en) | Process and system for preparing dry milk formula | |
EP2825058B1 (en) | Process for the humanization of animal skim milk and products obtained thereby | |
US10674739B2 (en) | Method for processing animal skim milk | |
ES2782473T3 (en) | Method to produce a starting formula base | |
NZ712773B2 (en) | Process and system for preparing dry milk formulae | |
NZ712768B2 (en) | Process and system for preparing dry milk formulae |